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ABSTRACT 
 
Centers for Disease Control and Prevention (CDC) estimate that more than 11.2 million 
people require critical and emergency care in the United States per year [1]. Optimizing and 
improving patient morbidity and mortality outcomes are the primary objectives of monitoring in 
critical and emergency care.  Patients in need of critical or emergency care in general are at a risk 
of single or multiple organ failures occurring due to a traumatic injury, a surgical event, or an 
underlying pathology that results in severe patient hemodynamic instability. Hence, continuous 
monitoring of fundamental cardiovascular hemodynamic parameters, such as heart rate, 
respiratory rate, blood pressure, blood oxygenation and core temperature, is essential to 
accomplish diagnostics in critical and emergency care.  Today’s standard of care measures these 
critical parameters using multiple monitoring technologies.  
Though it is possible to measure all the fundamental cardiovascular hemodynamic 
parameters using the blood flow dynamics, its use is currently only limited to measuring 
continuous blood pressure. No other comparable studies in the literature were successful in 
quantifying other critical parameters from the blood flow dynamics for a few reasons. First, the 
blood flow dynamics exhibit a complicated and sensitive dynamic pressure field. Existing blood 
flow based data acquisition systems are unable to detect these sensitive variations in the pressure 
field. Further, the pressure field is also influenced by the presence of background acoustic 
interference, resulting in a noisy pressure profile. Thus in order to extract critical parameters from
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this dynamic pressure field with fidelity, there is need for an integrated framework that is 
composed of a highly sensitive data acquisition system and advanced signal processing. In 
addition, existing state-of-the-art technologies require expensive instrumentation and complex 
infrastructure. The information sensed using these multiple monitoring technologies is integrated 
and visualized using a clinical information system. This process of integration and visualization 
creates the need for functional interoperability within the multiple monitoring technologies. 
Limited functional interoperability not only results in diagnostic errors but also their complexity 
makes it impossible to use such technologies to accomplish monitoring in low resource settings.  
These multiple monitoring technologies are neither portable nor scalable, in addition to inducing 
extreme patient discomfort. For these reasons, existing monitoring technologies do not efficiently 
meet the monitoring and diagnostic requirements of critical and emergency care.   
In order to address the challenges presented by existing blood flow based data acquisition 
systems and other monitoring systems, a point of care monitoring device was developed to provide 
multiple critical parameters by means of uniquely measuring a physiological process. To 
demonstrate the usability of this novel catheter multiscope, a feasibility study was performed using 
an animal model. The corresponding results are presented in this dissertation.  The developed 
measurement system first acquires the dynamics of blood flow through a minimally invasive 
catheter. Then, a signal processing framework is developed to characterize the blood flow 
dynamics and to provide critical parameters such as heart rate, respiratory rate, and blood pressure.  
The framework used to extract the physiological data corresponding to the acoustic field of the 
blood flow consisted of a noise cancellation technique and a wavelet based source separation. The 
preliminary results of the acoustic field of the blood flow revealed the presence of acoustic heart 
and respiratory pulses.  A unique and novel framework was also developed to extract continuous 
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blood pressure from the pressure field of the blood flow. Finally, the computed heart and 
respiratory rates, systolic and diastolic pressures were benchmarked with actual values measured 
using conventional devices to validate the measurements of the catheter multiscope.  
In summary, the results of the feasibility study showed that the novel catheter multiscope 
can provide critical parameters such as heart rate, respiratory rate and blood pressure with clinical 
accuracy.  In addition, this dissertation also highlights the diagnostic potential of the developed 
catheter multiscope by presenting preliminary results of proof of concept studies performed for 
application case studies such as sinus rhythm pattern recognition and fetal monitoring through 
phonocardiography. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
Optimizing and improving patient morbidity and mortality outcomes are the primary 
objectives of monitoring in critical and emergency care.  Patients in the need of critical or 
emergency care in general are at a risk of single or multiple organ failure occurring due to a 
traumatic injury, surgical event or an underlying pathology. This risk causes the patients to 
experience a hemodynamic instability. This hemodynamic instability further leads to ineffective 
circulating volume, cardiac function and/or vascular tone, ultimately resulting in an inadequate 
tissue oxygen delivery, end organ perfusion and death. Today’s standard of care manages these 
instabilities by continuously monitoring various cardiovascular hemodynamic parameters (critical 
parameters) and thereby manipulating the macro and micro-circulation to improve tissue oxygen 
delivery [2] [3] [4]. Minimum standards of monitoring in critical and emergency care are specified 
by the college of intensive care medicine and they include continuous monitoring of fundamental 
critical parameters such as heart rate, respiratory rate, blood pressure (arterial and venous), blood 
oxygenation and core temperature [5].  From a systemic view, critical care monitoring can be 
summarized as a two stage process.  At the first stage, multiple sensors acquire vital bio-signals 
corresponding to various physiological processes of the patient. At the second stage, a clinical 
information system is used to integrate and visualize the data from the multiple sensors used in 
first stage.  State-of-the-art sensing technologies as shown in Figure 2.1, traditionally determine 
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critical parameters from the vital bio-signals, i.e., heart rate is determined either from 
Electrocardiogram (ECG) [6] or Photoplethysmograph (PPG) using 12 lead electrodes or a 
fingertip pulse oximetry; respiratory rate is determined either from respiratory flow or 
respiratory/lung sounds using a capnography or plethysmograph or a pneumatograph [7]; 
continuous blood pressure is determined by coupling the vascular pressures to an intravascular or 
extravascular pressure sensor through an arterial and/or venous catheter [8] [9]; blood oxygenation 
is determined from pulse oximetry [10] and core body temperature is measured using either a 
pulmonary arterial catheter or a urinary Foley catheter [11].   
 
Figure 1.1: Multiple Vital Bio-signal Monitoring in Critical and Emergency Care. Image 
Adapted From [12]. 
1.2 Existing Challenges in Critical and Emergency Care Monitoring 
Though it is possible to measure all the fundamental cardiovascular hemodynamic 
parameters such as heart rate, respiratory rate, blood oxygenation and core temperature from the 
blood flow, its use is currently only limited to measuring continuous blood pressure. No other 
comparable studies in the literature were successful in quantifying multiple critical parameters 
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from the blood flow dynamics for a few reasons. First, the blood flow dynamics exhibit a 
complicated and sensitive dynamic pressure field. Second, existing blood flow based data 
acquisition systems are unable to detect these sensitive variations within the dynamic pressure 
field. Further, the dynamic pressure field is influenced by the presence of acoustic waves, resulting 
in a noisy pressure profile. Thus in order to extract critical parameters from this dynamic pressure 
field with fidelity, there is need for an integrated framework that is composed of a highly sensitive 
data acquisition system and advanced signal processing. Even though monitoring heart rate and 
cardiac arrhythmia is traditionally done using a 12-lead ECG, recent research shows that 
morphological characteristics of ECG change due to electrolyte, water and other chemical changes 
in the cardiovascular system. This change in chemical composition has a direct influence on the 
electrical activity of the heart, resulting in false alarms and consequently, diagnostic errors.  ECG 
is known for producing the highest quality measurement of heart rate, but it has been shown in the 
literature that heart rate measured from heart sounds is equally reliable as ECG [13]. Furthermore, 
the 12 lead ECG and the respiratory data acquisition systems cause extreme discomfort and restrict 
patient mobility. Although pulse oximetry is a gold standard monitoring technology for measuring 
blood oxygenation, the characteristics of the PPG signal are not fully understood among the 
medical community and it is still an area of active research [14] [15]. Also, blood oxygenation 
measurements of PPG are inaccurate when partial pressure levels of oxygen are high, and the 
inaccuracies also depend on properties of the skin which are highly subjective [16].  Further, core 
body temperature sensing technologies require the use of an additional catheter rather than using 
a preexisting arterial or venous line. Overall, the existing gold standard sensing technologies need 
multiple assessment systems in order to monitor critical cardiovascular hemodynamic parameters 
corresponding to various physiological processes. In addition, the existing clinical information 
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systems face limitations to achieve medical device interoperability, as accomplishing the 
integration and synchronization of various data acquisition systems used in the first stage is 
complicated. Existing information systems also do not acquire and store high resolution data. As 
a result, the complete morphology of the data acquired from various physiological sensors is not 
currently being used for clinical interventions. In addition, the current systems do not support the 
application of advanced data processing algorithms and consequently providing real time support 
for clinical decision making still remains as an unsolved challenge [17].  All the limitations of 
individual subsystems result in the following open challenges of critical and emergency care that 
need to be addressed. 
• Expensive Instrumentation and Complex Infrastructure: To achieve minimum standards of 
care, heart rate, respiratory rate, blood pressure, blood oxygen saturation and core body 
temperature need to be continuously monitored as initial biomarkers of health status. This 
implicates that the, use of 12-lead ECG, Capnography, Arterial Catheter, Plethysmography 
and Foley Catheter is imperative. Not only these multiple monitoring technologies induce 
extreme patient discomfort, but also demand complex infrastructure in terms of hardware 
and software, in addition to being very expensive. For these reasons, current state-of-the-
art critical monitoring technologies are ineffective and so in order to address this challenge 
of monitoring especially in low resource settings such as battlefields and emergency 
scenarios, a new approach is required.   
• Medical Device Interoperability: In current critical and emergency care, vital bio-signals 
are acquired from myriad physiological sensing technologies. Due to most of these 
technologies being stand-alone devices, they do not integrate with each other creating a 
limited functional interoperability. This lack of functional interoperability leads to issues 
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associated to time synchronization of the data acquired from various physiological 
processes, eventually leading to diagnostic errors. In addition, due to the limited 
interoperability, critical care diagnostics is subject to high false alarm rate. Though many 
solutions have been proposed to address this issue, interoperability remains as an open 
challenge to date. 
• Portability and Scalability: It has to be underlined that, existing critical and emergency 
care monitoring and diagnostic technologies are neither portable nor scalable. As a result, 
additional monitoring and diagnostic technologies are continuously brought in to meet the 
requirements of standard of care. The novel system presented in this work is portable, 
scalable and possibly applicable to multiple case studies of critical and emergency care.  
1.3 Motivation and Research Objectives 
Accomplishing monitoring from the dynamics of the blood flow is currently limited to 
measurement of continuous blood pressure. The hypothesis of this research is that, it is possible to 
extract other critical parameters such as heart rate, respiratory rate, blood oxygenation, and core 
temperature from the blood flow dynamics. Thus, our primary motivation of this research is to 
develop a novel point of care monitoring device that is capable of providing multiple critical 
 
Figure 1.2: Critical and Emergency Care Monitoring Using Novel Catheter Multiscope. 
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parameters by uniquely characterizing a physiological process, i.e., blood flow dynamics. Figure 
1.2 shows a basic overview of the concept of operations for the catheter multiscope monitoring 
critical parameters from a subject in critical and/or emergency care.   
Figure 1.3 shows the life cycle representation of the medical device development. 
Following the lifecycle, proof of concept and feasibility studies will be carried out to evaluate the 
usability of the catheter multiscope for critical care using a small animal model [18].  The proposed 
novel catheter multiscope is an enhanced version of the electronic catheter stethoscope [19] with 
respect to its data acquisition. In particular, the limitations of the existing blood flow based data 
acquisition systems in detecting the sensitive variations within the dynamic pressure will be 
addressed through integration of the enhanced data acquisition system and an advanced signal 
processing framework. The proposed novel catheter multiscope is expected to be a disruption in 
technology, such that, it will be potentially possible to address open challenges such as the need 
for expensive instrumentation and complex infrastructure; improvement in the diagnostic precision 
in low resource settings; and functional interoperability.  Further, the developed signal framework 
will also be extended to highlight the diagnostic potential of this technology for various case study 
applications. Specifically, proof of concept studies will be performed on applications such as sinus 
rhythm pattern recognition and fetal monitoring through phonocardiography. The proof of concept 
studies will demonstrate that the catheter multiscope can also be configured to be scalable and 
portable. 
 
 
 
Figure 1.3: Medical Device Life Cycle. 
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1.4 Contributions 
A novel critical and emergency care monitoring system has been developed to measure 
heart rate, respiratory rate, systolic and diastolic pressure with clinical accuracy from the blood 
flow dynamics. 
• Designed an innovative data acquisition system to uniquely characterize the blood flow 
dynamics.  
 The data acquisition system was designed to precisely characterize the sensitive 
dynamic pressure variations of the blood flow using a fluid coupled catheter and a novel 
polymeric membrane to act as fluid to air coupler. 
 The data acquisition system was also designed to deliver the pressure field without any 
distortions while minimizing other interferences using a waveguide. 
• Developed an innovative signal processing framework to extract vital bio-signals and the 
corresponding signal processing algorithms to compute critical parameters from the 
acquired blood flow dynamics. 
 Developed an efficient noise reduction algorithm to improve the signal to noise ratio 
of the acquired dynamic pressure field. 
 Developed a source separation algorithm to separate the data corresponding to various 
acoustic sources from a single channel observation. 
 Developed a validation metric to estimate the performance of denoising when the 
channel noise is not available. 
• Developed a procedure to validate and benchmark the performance of the proposed critical 
and emergency care data acquisition system.
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 Accomplished validation by comparing the critical parameters derived from the novel 
catheter multiscope to critical parameters derived from conventional measurement 
systems. 
In addition to demonstrating the feasibility of the developed novel catheter multiscope in 
critical and emergency care monitoring, the diagnostic potential of the developed technology has 
been shown in the following case studies. 
• Accurately recognized the sinus rhythm patterns using acoustic heart pulses from the novel 
catheter multiscope. 
 Developed a new feature called multiscale energy. 
 Developed a pattern recognition framework based on K-Means clustering. 
• Extracted the vital bio-signals of fetal phonocardiograms with fidelity. 
 Implemented the catheter stethoscope’s noise reduction and source separation 
framework to separate fetal and maternal heart sounds corresponding to various signal 
to noise ratio conditions of simulated fetal phonocardiograms 
 Validated the denoising and separation fidelity using validation metrics of the 
developed catheter multiscope. 
In comparison to the existing state-of-the-art, the developed critical and emergency care 
monitoring technology exhibits innovation in terms of complexity of the data acquisition system 
and a signal processing framework. The proof of concept and the feasibility studies show that the 
developed minimally invasive catheter multiscope can be used to measure critical parameters with 
clinical accuracy. It is expected that this dissertation will serve the needs of scientists, researchers, 
clinicians and other readers involved in the research and development of medical devices and 
biomedical signal processing. 
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1.5 Dissertation Organization 
The research that has been performed is organized and presented in the following chapters. 
1.5.1 Chapter 2: Survey of Critical and Emergency Care Monitoring Systems 
In this chapter, the background information about critical and emergency care monitoring 
and diagnostics is described. The diagnostic relevance of monitoring specific hemodynamic 
cardiovascular vital bio-signals in the critical and emergency care are also highlighted. A literature 
review on existing state-of-the-art critical care sensing technologies and clinical information 
systems is included in this chapter. In addition, a comprehensive introduction to various 
physiological signals (vital bio-signals) is presented from the perspective of the signal processing 
field.  
1.5.2 Chapter 3: Data Collection 
In this chapter, an overview of the human circulation system from the perspective of fluid 
mechanics and how various physiological systems influence the blood flow dynamics is provided. 
Then, how the data was collected for the feasibility study is described. Based on the fluid 
mechanics understanding of the human circulatory system, the interpretation of the collected data 
is provided. Finally, the chapter is concluded by laying the foundation for the development of the 
signal processing framework. 
1.5.3 Chapter 4: Signal Processing Framework 
In this chapter, a functional overview of the signal processing framework that was 
implemented to compute the vital bio-signals and critical parameters is provided. Further, a 
comprehensive description of the developed noise cancellation, the wavelet source separation and 
the novel blood pressure computation framework is presented. In addition, performance 
comparison results of various noise cancellation algorithms are provided. Finally, the chapter is 
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concluded by describing the validation results of wavelet source separation and blood pressure 
computation. 
1.5.4 Chapter 5: Application Case Studies 
In this chapter, an overview of special applications such as sinus rhythm pattern recognition 
and fetal monitoring through phonocardiography is provided. Further, a detailed description and 
results of feature extraction and pattern recognition framework for sinus rhythm pattern 
recognition are provided. Then, the chapter is concluded by providing the results of the noise 
cancellation and source separation techniques on the simulated fetal phonocardiograms.  
1.5.5 Chapter 6: Conclusions and Future Research 
A summary of the findings of this research is provided in this chapter. Then, directions for 
future research with respect to the data acquisition system design, data collection and signal 
processing framework have been provided in this chapter. In particular, the specifications and 
design for future generations of the data acquisition system is described. In addition, future 
directions for additional application case studies are also provided.  
11 
 
CHAPTER 2: REVIEW OF CRITICAL AND EMERGENCY CARE MONITORING 
PARAMETERS AND SYSTEMS 
 
 2.1 State-of-the-Art in Critical and Emergency Care Monitoring 
Critical and/or emergency care begins with minimum standards of monitoring. However, 
depending on the status of the patient, a full spectrum of hemodynamic cardiovascular parameters 
come into play that aid in determining the future clinical interventions. The complete set of critical 
parameters can be classified into four groups.  They are pressure, cardiovascular, respiratory and 
miscellaneous. In addition to the parameters, their respective sensing technologies are also shown 
in Table 2.1.  In addition to the traditional sensing technologies, a number of other alternative 
technologies are often employed to estimate other critical hemodynamic and respiratory 
parameters. This chapter provides an introduction to the morphology of all the vital bio-signals, 
an overview of all the fundamental hemodynamic parameters, a review of the existing sensing 
technologies, clinical information systems and other frequently used alternative technologies.  
Table 2.1: Critical and Emergency Care Cardiovascular Hemodynamic Parameters. 
Cardiovascular Parameters Sensing Technology 
Heart Rate (HR) ECG, PCG, Pulseoximetry, Blood Pressure 
Cardiac Output (CO) Dilution Methods, Pulse Wave Velocity Analysis and Bioimpedance 
 
Pressure Parameters Sensing Technology 
Mean Arterial Pressure (MAP) Arterial Catheter 
Central Venous Pressure (CVP) Central Venous Catheter 
Mean Pulmonary Arterial Pressure (MPAP) Pulmonary Arterial Catheter 
Pulmonary Arterial Occlusion Pressure (PAOP) Pulmonary Arterial Catheter 
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Table 2.1 (Contd.) 
Respiratory Parameters Sensing Technology 
Respiratory Rate (RR) Capnogram, Pneumatograph and ECG. 
End Tidal Carbon-dioxide Pressure (ETCO2) Capnogram 
 
Miscellaneous Parameters Sensing Technology 
Peripheral Oxygen Saturation (SPO2) Pulseoximetry 
Arterial Hemoglobin Saturation (SAO2) 
Blood Sampling Analysis and 
Pulseoximetry 
Arterial Oxygen Tension (PAO2) Blood Sampling Analysis 
Mixed Venous Oxygen Saturation (SVO2) Blood Sampling Analysis 
Mixed Venous Oxygen Tension (PVO2) Blood Sampling Analysis 
Arterial pH (pH) Blood Sampling Analysis 
Hemoglobin (Hgb) Blood Sampling Analysis 
Core Temperature (T) Pulmonary Arterial Catheter and Foley Catheter 
 
2.1.1 Electrocardiogram (ECG) 
ECG is a graphical representation of the electrical activity of the cardiovascular system. 
The wave-like pumping action of the heart is controlled by a network of neural fibers that are 
distributed throughout the myocardium and coordinate its regular contraction and relaxation. The 
myocardial stimulation starts from the Sinoatrial Node (SA-node). The SA-node is a cluster of 
cells located in the upper-right posterior wall of the right atrium, which sends the electrical impulse 
that triggers each heartbeat. This impulse further stimulates the second cluster of cells, namely the 
Atrioventricular Node (AV-node) that is situated in the lower posterior wall of the right atrium. 
After the AV-node, the depolarization front enters the bundle of His, the left and right bundles, 
and ends in the Purkinje fibers, depolarizing the ventricular muscles in its way. The procedure of 
myocardium contraction is known as the depolarization (or systole) cycle that is followed by the 
repolarization (or diastole) cycle, in which the myocardium relaxes and becomes ready for the next 
activation. A complete cardiac cycle is depicted in Figure 2.1.  This cardiovascular electrical 
activity is transmitted throughout the body and can be measured across the chest using either 1-
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lead or 3-lead or 5-lead or 6-lead or 12-lead skin electrodes. For critical and emergency care, 12-
lead ECG is considered the gold standard, due to its measurement accuracy [20].  
The ECG measured on the body surface is a result of the stage-wise activation of the 
myocardium and results in the PQRST-complex depicted in Figure 2.1.  The P-wave is the result 
of the atrial depolarization. This depolarization starts at the SA-node and spreads to ventricles 
through the AV-node. The QRS complex represents the ventricular depolarization. Then, atria and 
ventricles repolarize. However, atrial repolarization is obscured by the QRS complex and ventricle 
repolarization is represented through the T wave [21]. One of the main uses of ECG in the critical 
and emergency care is continuous monitoring of heart rate. The heart rate represents the time 
consumed by the heart to complete one cardiac cycle. The HR is one of the high priority critical 
parameters and is typically measured as the time interval between current and previous R-waves 
of ECG.  Arrhythmias are other leading cause of death among critical and emergency care patients. 
Hence, many critical and emergency care units detect arrhythmia through continuous ECG 
monitoring. In addition, ECG is also used to provide complimentary information about respiratory 
system through RR computation [22]. Though ECG provides significant diagnostic information, 
its use is limited due to some critical challenges. ECG data acquisition is complex and due to this, 
it is known to induce discomfort and restrict patient mobility. Studies like [23] [24] have often 
shown that morphological characteristics of the ECG change due to electrolyte, water and other 
chemical changes in the cardiovascular system. In the context of critical and emergency care, 
drugs, medication and nutrients are frequently delivered to induce changes in the micro and macro 
circulation. This often leads to changes in the cardiovascular system’s electrolyte composition. 
This composition change will result in diagnostic errors and false alarms due to the changes in the 
ECG’s morphological characteristics. Hence, there is an increased need to develop a medical 
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device that provides reliable and consistent results even during chemical composition change in 
the cardiovascular system and that addresses other ECG limitations. In addition to the ECG, an 
alternative technology that records acoustic activity of the heart is often used. This is known as 
phonocardiogram and it provides vital information with respect to cardiovascular abnormalities 
[13]. 
2.1.2 Blood Pressure (BP) 
High blood pressure is a leading risk factor responsible for high cardiovascular morbidity 
and mortality rates. Hence, precise and accurate monitoring of continuous blood pressure is 
imperative in critical and emergency care. The main function of the human circulatory system is 
to transport oxygen and other nutrients to the tissues and to carry waste away from the cells. The 
nutrients and the oxygen are carried to various parts of the body through oxygenated blood flow 
via arteries, and waste through deoxygenated blood flow via veins. The blood flows in the blood 
vessels due to the pumping action of the heart. The heart can be divided into four chambers and 
two pumping systems. Each pump has a filling chamber known as the atrium, which helps to fill 
a pumping chamber known as the ventricle. The oxygenated blood flows from the lungs into the 
left ventricle through left atrium and mitral valve. The left ventricle then ejects the blood into the 
aorta through the aortic value. Blood is then distributed to various parts of the body through 
branching network of arteries, arterioles and ventricles. Similar to the arterial system, the 
deoxygenated blood from different parts of the body reaches the right atrium through the venous 
system. The deoxygenated blood flows into the right ventricles through the tricuspid valve and 
into the pulmonary artery through the pulmonary valve. During diastole, the atria contract to 
generate sufficient pressure to open the mitral and tricuspid valves, thereby filling the ventricles. 
Then, during systole, aortic and pulmonary valves open due to pressure generated by ventricular 
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contraction. This mechanical contraction of the ventricles forces the blood to flow in arteries and 
veins [8]. In effect, the flowing blood exerts pressure onto the walls of the blood vessels 
contributing to blood pressure.   
 
Figure 2.1: Morphology of the Electrocardiogram. Data Obtained from MIT–BIH Long-Term 
ECG Database [25]. 
Many technologies exist to measure blood pressure. They can be classified into three 
groups based on the measurement technique: invasive, oscillometric and unobtrusive, also known 
as cuffless. In the context of critical and emergency care, since continuous monitoring of the blood 
pressure is imperative, invasive blood pressure measurement is considered to be the gold standard. 
Invasive blood pressure measurement typically involves the use of a catheter. Based on the location 
of the sensing element, invasive measurement can be further classified into intravascular and 
extravascular measurement systems. In the extravascular pressure measurement systems, the 
vascular pressure is fluid coupled to an external sensing element. The catheter is inserted into the 
arterial or venous system through a cannula, where the proximal end of the cannula is immersed 
in the blood and the distal end is connected to the proximal end of the fluid filled catheter. The 
distal end of the fluid filled tube is connected to either a drug delivery system or a saline delivery 
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system.  The column that couples the vascular pressure through fluid to the diaphragm of the 
pressure transducer is housed before the drug delivery system as shown in Figure 2.2.  
 
Figure 2.2: Invasive Extravascular Pressure Measurement System. 
On the other hand, in the intravascular pressure measurement systems, the sensing element 
is housed at the tip of the catheter and is placed directly into the vascular system. Among non-
invasive blood pressure measurement techniques, the oscillometric technique is a widely used 
method. The oscillometric techniques estimate the blood pressure through auditory detection of 
the turbulent blood flow sounds occurring due to inflation of the occlusive cuff around an artery. 
These turbulent blood flow sounds are detected using a stethoscope by stepwise deflation of the 
inflated cuff. The pressure detected at the first and the last instances of the turbulent blood flow 
sounds are considered to represent pressure during systole and diastole, respectively. Unobtrusive 
blood pressure monitoring methods are among recent developments and are still under research. 
The objective of unobtrusive monitoring is to estimate blood pressure continuously and non-
invasively. Existing unobtrusive methods estimate blood pressure by linearly or nonlinearly 
modeling the pulse transit time or the pulse wave velocity. Pulse transit time or pulse wave velocity 
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is currently being measured using either electrical, optical, magnetic, mechanical or impedance 
based sensing technologies [8] [26] [27]. 
It is worth noting that the blood pressure is different at various body sites. In particular, 
arterial pressure, central venous pressure and pulmonary arterial pressure are the most widely 
monitored vital bio-signals in critical and emergency care. Arterial pressure is representative of 
pressure of blood exerted on the walls of arteries. This pressure is commonly measured in radial, 
femoral, carotid arteries or aorta through the use of an arterial catheter. The arterial pulse is a 
forward propagating pressure wave that is generated due to stroke volume changes during each 
cardiac cycle. The arterial pressure waveform is a periodic waveform that can be represented as a 
summation of six sinusoidal components. Each local maxima in the waveform occurs when the 
ventricle contracts and forces the blood into the aorta, this is referred to as systolic pressure. 
Similarly, local minima in the waveform occur after the aortic valve closes and when the ventricles 
relax; this is referred to as diastolic pressure. In addition, the arterial pressure waveform also 
reflects the valve closure as a high frequency interruption in the signal and it is commonly referred 
to as the dicrotic notch. As the pressure reaches the minima, the aortic valve opens and the blood 
starts flowing into the aorta, usually seen as an increasing signal with positive slope and the 
pressure reaches a local maxima. This process periodically repeats for each cardiac cycle [28]. 
From the arterial blood pressure vital bio-signal, critical parameters such as systolic, diastolic and 
mean arterial pressures are estimated. The critical parameters estimated from arterial blood 
pressure vital bio-signal contain information with respect to afterload, i.e., tension developed by 
the myocardium during ventricular systolic ejection [5] [29]. In addition to the after load, 
information with respect to preload is also another parameter that is measured in critical and 
emergency care. Preload provides information with respect to intravascular volume, i.e., amount 
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of blood returned to the heart which is reflective of perfusion abnormalities. This is accomplished 
by measuring CVP, i.e. pressure in the right atrium, using a central venous catheter. The CVP 
waveform is typically represented by acxvy components. Each component of the CVP waveform 
has a direct relevance to the events of a cardiac cycle [30]. Pulmonary arterial pressure is another 
vital bio-signal that is continuously monitored for high risk patients in critical and emergency care. 
The pulmonary arterial pressure is measured using a balloon tipped Swan-Ganz catheter. The 
Swan-Ganz catheter is typically placed in pulmonary artery and the pressure is recorded. In 
addition, when the balloon tip of the catheter is inflated and placed in a branch of the pulmonary 
artery, the measurement results in the PAOP. The waveforms of the pulmonary arterial pressure 
and the PAOP are also characterized by the a, the c and the v components. MPAP and mean PAOP 
(MPAOP) are the critical parameters that are computed from pulmonary arterial pressure signals 
[31] [32].  In addition to pulmonary arterial catheter, recent developments have led to the 
assessment of MPAP and MPAOP using ultrasound technology [33] [34] [35].  Figure 2.3 shows 
various waveforms collected as of part of intensive care monitoring in The Massachusetts General 
Hospital and published as “The MGH/MF Waveform Database” in the PhysioNet databank [36] 
[25]. 
Various technologies exist to assess the pressure based vital bio-signals and the 
corresponding critical parameters. In the context of critical care, catheter based pressure 
measurements are considered to be gold standard to date. However, these catheter based pressure 
measurement systems provide limited information. As of today, these systems only provide blood 
pressure information. However, in order to get information with respect to other fundamental 
critical parameters, today’s standard of care has to rely on other technologies. With few 
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modifications, the catheter based systems will be able to provide all the fundamental critical 
parameters. This is one of the main challenge that is addressed in this dissertation. 
 
Figure 2.3: Morphology of ECG, ART, PAP, CVP Bio-signals. Data Obtained from [36] [25]. 
 
2.1.3 Cardiac Output (CO) 
Cardiac output is one of the most important critical parameters that is continuously 
monitored for high risk patients in critical and emergency care. It is defined as the volume of blood 
pumped by the heart per minute.  CO is a widely used diagnostic tool to detect various conditions 
including cardiovascular shocks and also to determine if fluid resuscitation and other medications 
are needed based on the hemodynamic profile. Traditionally in critical and emergency care, CO is 
measured using a pulmonary arterial catheter and a dilution technique. In the dilution techniques, 
an agent of known concentration and temperature is injected into the right atrium through the distal 
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end of the pulmonary arterial catheter. Due to constant stroke volume change, the concentration of 
the mixture of agent and blood starts reducing and the temperature of the blood changes. This 
change in the temperature of the blood is monitored constantly as the thermodilution curve. The 
measured temperature and the initial volume of the agent in combination will be used to determine 
the CO [37]. CO can also be estimated using ultrasound and echocardiography, in particular, the 
distance traveled by a column of blood for each cardiac cycle is estimated, i.e., blood flow velocity. 
The measured blood flow velocity is directly proportional to stroke volume and hence CO. CO can 
also be estimated using technologies that involve bioimpedance and pulse contour analysis 
techniques. In the bioimpedance method, the change in the impedance of the electrodes placed on 
the chest is directly correlated to the blood volume change used to estimate the CO. On the other 
hand, the pressure pulse velocity is determined using either electrical, optical, magnetic, 
mechanical or impedance based sensing technologies which can be linearly or nonlinearly modeled 
to estimate CO. Based on the techniques discussed, various alternative sensing technologies have 
been developed to provide information with respect to CO as described in [38] [39]. 
2.1.4 Capnography 
Continuous monitoring of the cardiorespiratory system is essential to provide necessary 
ventilation support for patients in critical and emergency care. Although, different parameters 
provide relevant information with respect to the respiratory system, RR and ETCO2 are the 
essential critical parameters being used today. They are typically derived from the capnogram, a 
vital bio-signal. Capnography is a method used to detect the concentration of carbon-dioxide in a 
sample of gas. The sample of gas exchanged by the patient is collected either through a nasal 
cannula or through an intubation tube for absorption spectroscopic analysis. As the carbon-dioxide 
absorbs the infrared light, the transmitted spectra is analyzed and calibrated to provide the 
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concentration of carbon-dioxide in the subject’s gas sample. Measuring and tracing this carbon-
dioxide concentration over time will result in the vital bio-signal called capnogram. The 
capnogram is a periodic waveform that represents events of a complete respiratory cycle. The 
events of respiratory cycle are inspiration, expiratory stroke, expiratory plateau and expiratory 
downstroke. During inspiration, the concentration of the carbon dioxide remains to be at a 
consistent baseline line, then as the expiratory begins, the alveolar gases get emitted. The alveolar 
gases predominantly contain carbon dioxide and hence its concentration begins to reach a local 
maxima, i.e., gets plateaued. After the complete volume of alveolar gases get expired, the 
inspiration begins. Right after inspiration, and before expiratory plateau, there is a momentary 
dead space when the both the inspiratory and alveolar gas exchange ends, this region is known as 
expiratory stroke. Also, as soon as the concentration of carbon dioxide reaches a local maxima, 
there exists some dead space when both the expired and inspired gas exchange end, this is known 
as the expiratory downstroke. From this waveform, critical parameters, RR and ETCO2 are 
computed. RR is computed as time expired for both inspiration and expiration per minute; ETCO2 
is the maximum concentration of the CO2 in the expired gas i.e., the local maxima of the event 
expiratory plateau. In addition to time-based capnogram, volume based capnogram is also widely 
used. Additional details on capnography based cardiorespiratory monitoring and trends in 
capnography technologies are presented in [40] [41] [42]. In addition, volume based critical 
parameters such as tidal volume, vital and total lung capacities are measured using spirometers, 
pneumatographs and other alternative technologies [43]. 
2.1.5 Plethysmograph 
Ensuring oxygen delivery to tissues is one of the main objectives of the cardiorespiratory 
system. During respiration, the inspired oxygen in the lungs bind to deoxygenated blood, making 
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it oxygenated blood. Most of the oxygen in the lungs bind to hemoglobin. Small amount of oxygen 
dissolves in the blood plasma. This oxygenated blood is then pumped out of the heart into the 
aorta, and then into the arteries, arterioles and eventually into the capillary networks. These 
networks of capillaries supply tissues with oxygen and nutrients. Plethysmograph is a tracing of 
the amount of oxygen that is bound to hemoglobin at the tissue level, also known as SPO2. The 
oxygenated and deoxygenated hemoglobin levels in the blood are detected using absorption based 
infrared spectroscopy transcutaneously. The vital bio-signal waveform obtained using 
spectroscopy is known as plethysmography or pulse oximetry. This waveform contains 
information with respect to arterial blood, tissue, and respiration. It contains an AC and a DC 
component. The percentage of SPO2 is the critical parameter that is calculated using amplitude 
ratios of both the AC and the DC components of plethysmography. It has to be noted that, SPO2 
is considered to be an indirect measurement of SAO2. Additional details of the plethysmography 
are described in [44] [45].  
2.1.6 Miscellaneous Critical Parameters 
Arterial hemoglobin saturation (SAO2), arterial oxygen tension (PAO2), mixed venous 
oxygen saturation (SVO2), mixed venous oxygen tension (PVO2), arterial pH (pH), hemoglobin 
(Hgb) and core temperature (T) are among the other miscellaneous critical parameters that are 
often measured in critical and emergency care. SAO2 is the measurement of concentration of 
oxygenized hemoglobin in the arterial blood and PAO2 is the measurement of concentration of the 
oxygen dissolved in arterial blood plasma. In addition to critical parameters corresponding to the 
arterial blood, parameters corresponding to venous oxygenation such as SVO2 and PVO2 are also 
measured. SVO2 is the measurement of oxygen concentration bound to hemoglobin in venous 
blood, and PVO2 is the measurement of oxygen concentration dissolved in venous blood plasma.  
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These parameters are measured using either blood sampling analysis or by using an indwelling 
fiber optic catheter. In blood sampling analysis, a column of blood is sampled from either an 
arterial or a venous body site and is subjected to spectroscopic analysis using blood gas analyzers. 
In order to measure the concentration of the blood plasma in arterial or venous blood, the blood 
cells are separated from blood plasma either using centrifugal techniques or using a reagent. Then, 
the plasma is made to interact with a metal testing strip to determine the concentration of 
compounds of interest in the plasma. In addition, various alternative techniques involving 
spectroscopy systems in combination with linear and nonlinear modeling are being developed for 
rapid blood analysis. It also has to be noted that, other parameters such as total hemoglobin, 
concentration of other electrolytes and acidity level within the blood are monitored for patients 
with advanced risk in critical and emergency care. Core temperature is also a parameter that is 
usually measured from a sample extracted from either pulmonary arterial catheter or urinary Foley 
catheter. Additional information regarding miscellaneous parameters and electrolyte concentration 
is provided in [46] [47] [48] [49].  
2.1.7 Clinical Information Systems 
It is well established that there are several vital bio-signals corresponding to various 
physiological processes that must be continuously monitored in critical and emergency care. In 
addition, various critical parameters corresponding to the vital bio-signals are also continuously 
computed and monitored. A clinical information system is often employed in critical and 
emergency care to integrate and visualize the critical parameters and vital bio-signal collected from 
corresponding physiological processes. As of today, several clinical information systems are 
commercially available to provide end-to-end solutions to integrate diverse patient sensing or 
monitoring systems. It is estimated that the market value for these system has exceeded $1.3 billion 
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due to the volume of information available in the intensive and emergency care setting. Currently, 
GE’s Centricity and Philips IntelliVue Clinical Information Portfolio are the most commonly used 
commercial critical and emergency care information systems [17]. The vital bio-signals 
corresponding to various physiological processes are typically generated by standalone sensing 
technologies and either analog or digital data is available depending on the technology. The data 
available from these technologies is integrated through either a serial (RS-232 or I2C or USB),  
Ethernet (802.3) port or using wireless (802.11b/g or Bluetooth) communication for digital data. 
For analog data, standard hardware interfaces are used. Though, high resolution physiological data 
is not collected, snapshots of the acquired vital bio-signals and critical parameters are displayed 
on monitors to aid in the clinical decision making. In addition, a standard architecture to integrate 
and acquire continuous physiological data is yet to be established. Recent developments in clinical 
information systems can be found in [17]. 
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CHAPTER 3: DATA COLLECTION 
 
3.1 Fluid Mechanical Perspective of Blood Circulation 
The circulatory system can be described as a closed loop system that is directly regulated 
by the cardiovascular system and the respiratory system and controlled by the nervous system. As 
a result, the dynamics of the blood flow is influenced by factors such as length of cardiac cycle, 
stroke volume, rate of respiration, volume of respiration and baroreflex control. This complex 
interrelationship within various subsystems of the human body make the dynamics of the blood 
flow an interesting phenomenon. Several studies in the literature have underlined the significance 
of various factors that affect the blood flow, Cardiac Output (CO), i.e., the amount of blood 
pumped by the heart per minute, which is usually computed as a product of HR and stroke volume. 
Thus, increasing the heart rate or increasing the contractile strength of the ventricles, i.e., stroke 
volume, CO can be increased. In addition, it is well established that variability of heart rate is 
influenced by the baroreflex control and the breathing in the form of Meyer waves and respiratory 
sinus arrhythmia [50] [51]. In addition to CO, blood flow dynamics is also affected due to the 
properties of the arteries and veins. The properties of the arteries and veins such as elasticity, 
vascular resistance and thus the diameter of the corresponding blood vessels are controlled by the 
baroreflex feedback [52] [53]. Studies have also shown that baroreflex controls the dynamics of 
the blood flow based on the respiratory parameters such as volume and rate of respiration [54] [55] 
[56] [57] [58].  
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The circulatory system can be approximated as a fluid pumping system as shown in Figure 
3.1. In Figure 3.1, the deoxygenated blood is collected from the organs and is sent to the lungs. 
Then, the oxygenated blood is collected from the lungs and is distributed to the organs. According 
to Bernoulli’s principle, the total energy of any frictionless fluid flow is conserved.  As a result, 
blood flow in the blood vessels can be described using Bernoulli’s principle. The total energy of 
the blood flow in any blood vessel is the summation of its static pressure, dynamic pressure and 
gravitational head. The static pressure of the fluid is the pressure generated due to the force exerted 
by all the fluid elements on each other i.e. intramolecular pressure. In the case of steady state flow, 
the static pressure is directly dependent on the volumetric flow rate of the fluid. Due to this static 
pressure, the blood exerts pressure in all directions including on the walls of the blood vessels, 
contributing to blood pressure. In addition, since the blood is pumped with some velocity by the 
ventricular contraction during each cardiac cycle, the fluid also contains kinetic energy that is 
directly proportional to its velocity. This kinetic energy is often referred to as dynamic pressure. 
In addition, the pulsatile flow of blood influences the flow within the blood vessels with an 
unsteady acceleration. Overall, the pressure wave propagates mainly due to radial and axial fluid 
motion. While radial motion is due to the static pressure, axial motion is due to the dynamic 
pressure [8] [59]. Also, since the pressures are acquired at an increased elevation, the fluid also 
exhibits gravitational head due to the weight of the fluid. As of to date, blood flow has been mainly 
used to obtain information with respect to blood pressure. However, since the blood flow dynamics 
contain a plethora of information in the form of multi-dimensional pressure wave with regards to 
various cardiovascular, respiratory, and other subsystems, the blood flow dynamics was selected 
as a phenomenon of interest to obtain multiple critical parameters. In this dissertation, a novel data 
acquisition system was designed to characterize the blood flow dynamics and to obtain information 
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with respect to multi-dimensional pressure field. The details of the design and the data collection 
are provided in the following sections1,2.  
 
Figure 3.1: Fluid Pumping System Approximation of Circulatory System. 
3.2 Data Acquisition System Design 
 Figure 3.2 illustrates the block diagram overview of the data acquisition system that was 
used to determine multiple vital bio-signals from the animal model. As shown in Figure 3.2, the 
system includes a silicone or polyvinylchloride catheter comprising a flexible tube that is 
configured for insertion in a subject’s blood vessel, such as an artery or vein. When inserted, the 
distal end of the catheter is immersed in the blood that flows through the vessel. The proximal end 
of the catheter is received by, and therefore connected to, a coupling member that is, in turn, 
connected to a waveguide. As is also shown in Figure 3.2, a port has been provided along the 
                                                          
1The content described in Chapters 3 and 4 are part of US provisional [122] and utility patent applications [123]. 
2A preliminary version of the content presented in Chapter 3 and 4 have been published in the proceedings of 39th 
annual international conference of the IEEE Engineering in Medicine and Biology Society [121]. 
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length of the catheter between its distal and proximal ends that can be used to flush the catheter 
with an appropriate fluid, such as saline solution. Mounted to the coupling member is a flexible 
barrier. This barrier is formed using a thin polymeric membrane that is on a first side in fluid 
communication with the blood delivered to the coupling member by the catheter and on a second 
side in fluid communication with air contained within an interior air chamber of the waveguide. 
At the proximal end of the waveguide, a pressure field microphone isolated from the environment 
is housed to measure the pressure within the waveguide. The waveguide that is housing the 
pressure field microphone is mounted on a vibration isolating stainless steel tray. In addition, a 
free field microphone placed within close proximity to the subject is also used to measure reference 
acoustic noise. Specifically, the free field microphone is directed towards the subject using a 
stainless steel holder mounted on a tripod. It also has to be noted that both pressure and free field 
microphones were located at the same elevation from the ground as that of the subject and forming 
an angle less than 45o among themselves during the measurement. In the current feasibility study, 
a GRAS 46 AD, a pressure field microphone with frequency response of 3.15 Hz – 10 kHz and a 
G.R.A.S 46 AE, a free field microphone, have been used to measure pressure field and reference 
acoustic noise respectively [60] [61]. Since both G.R.A.S microphones require a constant current 
power supply of 4 mA and 24 V for optimal performance, a National Instruments PXI 4462 system 
is used to provide constant power to the microphones through a British naval connector. The 
measured data from both the channels was digitized and stored at a sampling frequency of 10 kHz 
and 24 bit quantization rate using PXI 4462 system and LabVIEW data acquisition drivers [62]. 
As shown in Figure 3.2, the waveguide is designed to be conical and special attention has been 
paid to estimate the ideal distance between the barrier and the microphone based on the length of 
the sensing element. These design considerations have enabled maximal energy transfer while 
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attenuating the effects of reflections and reverberation and without distorting the frequency of the 
actual pressure wave. 
 
Figure 3.2:  Block Diagram Representation of the Data Acquisition System.  
3.3 Data Collection Approach 
The data collection approach defines type and location of the data being acquired.  Vascular 
pressures were obtained from various arterial and venous body sites of an anesthetized Yorkshire 
pig in supine position.  The obtained vascular pressures were coupled from the subject to the 
extravascular pressure field microphone through a fluid coupled catheter using a preexisting 
arterial or venous line.  A total of twelve pressure measurements were obtained from six different 
body sites as part of this study.  Two different pressure measurements were obtained at each body 
site, one without the influence of epinephrine and other with influence of epinephrine. Table 3.1 
illustrates the sequence in which the design of experiments was conducted for all the acquired 
pressure measurements. In addition, heart rate, respiratory rate and blood pressure were measured 
prior to and post the vascular pressure acquisition for the purpose of benchmarking. These 
parameters were obtained from the state-of-the-art Philips IntelliVue critical care clinical 
information system. It has to be noted that, this study was performed by strictly adhering to ethical 
standards of the Institutional Animal Care & Use Committee. In addition, all the animal studies 
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corresponding to this research were performed at the University of South Florida’s Center for 
Advanced Medical Learning and Simulation facilities eCath laboratory. Appendix B contains 
relevant documentation with regards to IACUC approval for the animal studies. 
Table 3.1: Design of Experiments For Measured Blood Flow Dynamics. 
Recording 
Index Body Site 
Catheter 
Size Epinephrine 
1a Artery Carotid Left Side of Neck 5F No 
1b Artery Carotid Left Side of Neck 5F Yes 
2a Venous Jugular Right Side of Neck 5F Yes 
2b Venous Jugular Right Side of Neck 5F No 
3a Venous Femoral Right Leg 4F No 
3b Venous Femoral Right Leg 4F Yes 
4a Venous  Femoral Left Leg 6F Yes 
4b Venous Femoral Left Leg 6F No 
5a Artery Peripheral Left Ear 20F No 
5b Artery Peripheral Left Ear 20F Yes 
6a Artery Femoral Left Leg 5F No 
6b Artery Femoral Left Leg 5F Yes 
      
3.4 Description of the Measurements 
The blood flows from the venous or arterial body site into the catheter and reaches the 
flexible barrier that stagnates the flow of blood and ultimately acts as a fluid to air coupler.  At this 
boundary, the blood column oscillates and this oscillation depends on the frequency of stagnation 
pressure of the blood flow, i.e., the frequency at which the blood is being pumped.  The stagnation 
pressure that is impinged onto the barrier induces a pressure field in the waveguide. According to 
the basic principles of fluid mechanics, the total pressure (Ptotal) is the sum of static pressure (Pstatic) 
and dynamic pressure (Pdynamic) [63].  Pstatic results from intramolecular interaction and Pdynamic 
results from the velocity of the blood flow. These pressures are traditionally measured using a 
combination of piezometer and Pitot tube.  Based on the configuration in which the pressure field 
microphone was arranged to acquire pressure data, it was considered that the measured pressure is 
Ptotal.  In order to understand how the stagnation pressure or total pressure is being measured, 
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Bernoulli’s equations are used in the following derivation as means to provide a theoretical 
understanding of the measurements. Figure 3.3 presents a zoomed in view of the data acquisition 
system that was used is measuring Ptotal of the blood flow. 
 
Figure 3.3: Zoomed in View of the Data Acquisition System. 
As shown in Figure 3.3, the catheter orifice is at point 1, where point 1 is located at an 
elevation level h1 from the reference datum and the barrier, i.e., the stagnation point 2 is located at 
an elevation level h2 from the reference datum. In order to show that, the stagnation point 2 
experiences Ptotal, the Bernoulli’s energy conservation equations are written for points 1 and 2. 
Noting that at point 1, the static pressure is P1 and the velocity is V1 and at point 2, the static 
pressure is P2 and the velocity is V2. The following expression can be written using the Bernoulli’s 
principle. 
𝑃𝑃1 + 12 ρ𝑉𝑉12 + ρ𝑔𝑔ℎ1 = 𝑃𝑃2 + 12 ρ𝑉𝑉22 + ρ𝑔𝑔ℎ2 (1) 
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In equation (1), 1
2
ρ𝑉𝑉1
2 and 1
2
ρ𝑉𝑉2
2 are the dynamic pressures, ρgh1 and ρgh2 are gravitational 
heads at points 1 and 2, respectively. As the blood reaches the barrier, its velocity V2 at point 2 
becomes zero, resulting in the equations (2) and (3). 
𝑃𝑃1 + 12 ρ𝑉𝑉12 + ρ𝑔𝑔ℎ1 = 𝑃𝑃2 + ρ𝑔𝑔ℎ2 (2) 
𝑃𝑃1 + 12 ρ𝑉𝑉12 + ρ𝑔𝑔(ℎ1 − ℎ2) = 𝑃𝑃2 (3) 
Equation (3) proves that the barrier induces a pressure field equivalent to Ptotal into the 
waveguide. It was also observed that the pressure field microphone partly cancelled out the Pstatic 
data from the acquired Ptotal data through a static pressure equalization vent that was originally 
designed to equalize the effect of ambient pressure [64] [65].  Therefore, it was concluded that the 
acquired Ptotal predominantly consisted of pressure data corresponding to Pdynamic and trace amounts 
of Pstatic.  This provided motivation to derive the Pstatic from the acquired Ptotal.  In standard invasive 
pressure measurement systems, Pstatic is the measured pressure and Ptotal is not measured. However, 
in this study, both Pdynamic and Pstatic were measured by uniquely characterizing the acquired Ptotal 
as described in the next chapter.  
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CHAPTER 4: SIGNAL PROCESSING FRAMEWORK 
 
4.1 Background of Processing Blood Flow Dynamics  
The signal processing framework shown in Figure 4.1, follows a basic approach in the 
extraction and analysis of Pstatic and Pdynamic from the measured Ptotal.  Analyzing the acoustic field 
using the Pdynamic processing framework resulted in the acoustic heart and respiratory pulses.  
Reconstructing the pressure field using the Pstatic processing framework resulted in the extraction 
of continuous blood pressure, i.e., systolic and diastolic pressures.  Pstatic will be referred to as the 
pressure field and Pdynamic as the acoustic field of the blood flow in the rest of this dissertation.  As 
shown in Figure 4.1, the acoustic field was processed using noise reduction and source separation 
algorithms and the pressure field was processed using a novel compression and a sensor 
attenuation factor regression model to result in the corresponding vital bio-signals. 
 
Figure 4.1: Signal Processing Framework to Extract Vital Bio-signals from the Blood Flow 
Dynamics. 
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4.2 Acoustic Heart and Respiratory Pulse Computation Framework 
Analysis and processing of Pdynamic is viewed as a problem that requires a combination of 
active noise cancellation and source separation for SNR improvement and bio-signal extraction.  
Pdynamic is the result of acoustical sound pressure created by the oscillation of the blood column at 
the boundary of the barrier. Effectively, it is the sound of the blood flow or the acoustic field of 
the blood flow.  Since the measurement was made in a noisy clinical setting, the blood flow sound 
was interfered by other acoustical sources present in the setting.  Thus, in order to extract the bio-
signals with fidelity from this measurement, the acquired Pdynamic needed to be enhanced using a 
noise cancellation technique.  Further, a comparative performance evaluation of spectral 
subtraction and various Least Mean Squares (LMS) based adaptive noise cancellation techniques 
was accomplished based on Noise Factor (NF) and Signal to Noise Ratio (SNR).  In order to extract 
multiple bio-signals from the noise enhanced signal, a source separation technique based on 
Multiresolution Analysis (MRA) was also developed.  The block diagram of the developed 
framework for processing the blood flow acoustics is shown in Figure 4.2. In Figure 4.2, 
measurements from the G.R.A.S 46 AD and 46 AE microphones are processed using noise 
cancellation and source separation blocks to obtain the vital bio-signals. 
 
Figure 4.2:  Overview of Blood Flow Sound Processing. 
4.2.1 Noise Cancellation 
In the noise cancellation block, the microphone measurements are subject to initialization 
where the data is decimated and segmented into frames. Then, the segmented data from both 
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channels is processed using noise reductions algorithms that include spectral subtraction and LMS 
based adaptive noise cancellation algorithms as described in the following subsections. 
4.2.1.1 Spectral Subtraction 
Spectral subtraction is a widely employed technique in applications that require 
cancellation of interference from acoustic noise.  Many studies used a single channel spectral 
subtraction technique that assumed stationarity of the noise in order to improve the SNR of the 
sound pressure measurement [66, 67, 68].  However, it has been shown by studies [69, 70] that a 
multichannel spectral subtraction is not only computationally simple but also very efficient in 
improving the SNR of sound pressure measurements, particularly when a part of the reference 
acoustic noise is assumed to be superimposed into the sound pressure measurement by means of 
an unknown system as shown in Figure 4.3.  The fluid filled catheter and the waveguide from the 
data acquisition system, as shown in Figure 3.3, were identified as the major components of the 
system with unknown impulse responses through which the noise, n(n), that is correlated to the 
reference acoustic noise, n0(n), gets superimposed onto the desired signal, x(n).  In this study, a 
spectral magnitude subtraction technique was implemented to remove the noise superimposed onto 
the data channel.  Figure 4.3 shows the block diagram of the implemented spectral subtraction 
algorithm. 
 
Figure 4.3: Block Diagram Representation of the Implemented Spectral Subtraction 
Algorithm. 
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In Figure 4.3, the implemented spectral subtraction algorithm includes a data channel that 
measures the acoustic field of the blood flow dynamics, d(n), where n is the sample index, and a 
noise channel that measures reference acoustic noise from the clinical setting, n0(n).  The noisy 
measurement, d(n), acquired in the data channel is a result of superimposition of the desired signal, 
x(n) and a manifestation of the reference acoustic noise, n(n).  Equation (4) provides time domain 
model for the noisy measurement.  
d(n) = x(n) + n(n) (4) 
Here, d(n) and n0(n) were passed through an initialization block that decimated the signals 
from 10 kHz to 1 kHz and then segmented to 2 second long frames with 80% overlap.  Each data 
frame, di(n), where i is the frame index, and noise frame, n0i(n), was windowed using a rectangular 
window and transformed into the frequency domain using the Discrete Fourier Transform (DFT).  
Then, each incoming frequency transformed data frame, 𝐷𝐷𝑖𝑖(𝑓𝑓), and noise frame, 𝑁𝑁0𝑖𝑖(𝑓𝑓), were 
subjected to magnitude spectral subtraction to provide an estimate of the desired signal |𝑋𝑋�𝑖𝑖(𝑓𝑓)| as 
shown in equation (5). 
�𝑋𝑋�𝑖𝑖(𝑓𝑓)� =  |𝐷𝐷𝑖𝑖(𝑓𝑓)|  −  �𝑁𝑁0𝑖𝑖(𝑓𝑓)� (5) 
Equation (5) resulted in processing distortions by producing negative values in the 
estimated magnitude spectrum owing to the variations of the noise channel spectrum.  Hence, the 
estimated magnitude spectrum, |𝑋𝑋�𝑖𝑖(𝑓𝑓)|, is processed by the spectral flooring function to prevent 
negative values in the estimated magnitude.  Equation (6) presents the function that was used to 
perform spectral flooring [66, 71]. 
|𝑋𝑋�𝑖𝑖(𝑓𝑓)|= �0.01|𝐷𝐷𝑖𝑖(𝑓𝑓)|        if   |𝑋𝑋�𝑖𝑖(𝑓𝑓)| < 0|𝑋𝑋�𝑖𝑖(𝑓𝑓)|               otherwise  (6) 
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The spectral floored magnitude spectrum estimate,|𝑋𝑋�𝑖𝑖(𝑓𝑓)|, is combined with the phase of 
the noisy signal spectrum, θ(𝐷𝐷𝑖𝑖(𝑓𝑓)), and then transformed into the time domain via the Inverse 
DFT (IDFT).  Finally, concatenating the outputs from the IDFT yielded an estimate of the desired 
signal 𝑥𝑥�(𝑛𝑛). 
4.2.1.2 Adaptive Noise Cancellation 
Adaptive noise cancellation is another widely used multichannel noise cancellation 
technique to remove acoustic noise interference.  In particular, the current research evaluates the 
performance of the various adaptive noise cancellation algorithms in such a configuration where a 
part of the reference acoustic noise is assumed to be superimposed onto the data channel as shown 
in Figure 4.4.  In order to determine the best noise cancellation technique, the performance of the 
LMS, sign LMS, normalized LMS and fast block LMS algorithms were compared with spectral 
subtraction. 
 
Figure 4.4: Block Diagram Representation of the Implemented Adaptive Noise Cancellation 
Algorithm. 
The configuration considered in Figure 4.4 is similar to the case that was considered for 
the spectral subtraction based noise cancellation; where the noisy measurement, d(n), acquired in 
the data channel is a result of superimposition of the desired signal, x(n), and a manifestation of 
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the reference acoustic noise, n(n), as shown in equation (4).  It is the assumption that the desired 
signal, x(n), is statistically independent of n(n) and n0(n); n(n) and n0(n) are correlated in some 
sense.  In this algorithm, both d(n) and n0(n) were passed through an initialization block that 
decimated the signals from 10 kHz to 1 kHz and then normalized.  The normalized noise, n0(n), is 
filtered to produce 𝑛𝑛�(𝑛𝑛), an estimate of n(n) using minimum mean square estimation.  Equations 
(7), (8), and (9) represent filtering, error computation and weight update operations of the LMS 
based adaptive noise cancellation algorithm, respectively. 
𝑛𝑛�(𝑛𝑛) = 𝑤𝑤𝑇𝑇(𝑛𝑛) ∗  𝑛𝑛0(𝑛𝑛) (7) 
𝑒𝑒(𝑛𝑛) = 𝑑𝑑(𝑛𝑛) −  𝑛𝑛�(𝑛𝑛) (8) 
𝑤𝑤(𝑛𝑛 + 1) = 𝑤𝑤(𝑛𝑛) + µ 𝑥𝑥(𝑛𝑛)𝑒𝑒(𝑛𝑛) (9) 
In equation (7), 𝑤𝑤𝑇𝑇(𝑛𝑛) represents the computed coefficients of the adaptive filter based on 
the order (M), µ provides the step size for the weight update operation, e is the computed error 
which is considered to be the noise free estimate 𝑥𝑥�(𝑛𝑛) and n is the sample index.  In the current 
study, M was set to 300 and µ was set to 0.01 for LMS.  Sign LMS and normalized LMS were 
implemented using (10) and (11), respectively. 
𝑤𝑤(𝑛𝑛 + 1) = 𝑤𝑤(𝑛𝑛) + µ 𝑠𝑠𝑠𝑠𝑔𝑔𝑛𝑛(𝑥𝑥(𝑛𝑛))𝑒𝑒(𝑛𝑛) (10) 
𝑤𝑤(𝑛𝑛 + 1) = 𝑤𝑤(𝑛𝑛) + µ2 𝛥𝛥 + 𝜎𝜎𝑛𝑛0(𝑛𝑛)2  𝑥𝑥(𝑛𝑛)𝑒𝑒(𝑛𝑛) (11) 
In equation (10), sign represents a standard signum function. In equation (11), Δ is a 
constant and σ is the standard deviation of n0(n) which depends on the order of the filter.  For sign 
LMS, M was set to 300 and µ was set to 0.01.  For normalized LMS, M was set to 300, µ was set 
to 0.3 and Δ to 0.1.  The block LMS was implemented using a Fast Fourier Transform (FFT) based 
algorithm as described in [72].  The µ was set to 0.5, the block size and M were set to 300, the 
forgetting factor (γ) and initial average power estimate (P) were set to 0.1. 
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4.2.1.3 Performance Comparison of Noise Cancellation Algorithms 
In order to assess the performance of the implemented noise cancellation techniques, 
evaluation metrics based on the NF and the SNR estimated averages were computed after 
application of each noise cancellation technique.  The average of NF is estimated between the 
corresponding variances (σ2) of d(n) and 𝑥𝑥�(𝑛𝑛). Prior to computing the averages of NF and SNR, 
an estimate of the noise 𝑛𝑛�(𝑛𝑛) is computed by subtracting 𝑥𝑥�(𝑛𝑛) resulting from the noisy 
measurement, d(n).  Then, the SNR is estimated between the corresponding variances (σ2) of noise 
free estimate 𝑥𝑥�(𝑛𝑛) and 𝑛𝑛�(𝑛𝑛).  It should be noted that, d(n), 𝑥𝑥�(𝑛𝑛) and 𝑛𝑛�(𝑛𝑛) were segmented into 2 
second long frames with 80% overlap before estimating the averages of NF and SNR. In the 
equations (12) and (13) i, v, and l represent frame index, number of frames  and frame length 
respectively. NF is the ratio of powers of the noisy signal, di(n), to the noise free signal, 𝑥𝑥�𝑖𝑖(𝑛𝑛). On 
the other hand, SNR is the ratio of powers of noise free signal, 𝑥𝑥�𝑖𝑖(𝑛𝑛), to the estimated noise, 𝑛𝑛�𝑖𝑖(𝑛𝑛). 
NF = 1
𝑣𝑣
 ∑ 10 log �𝜎𝜎�𝑑𝑑𝑖𝑖(𝑛𝑛)�2
𝜎𝜎
� 𝑥𝑥�𝑖𝑖(𝑛𝑛)�2 �𝑣𝑣𝑖𝑖=1  (12) 
SNR = 1
𝑣𝑣
 ∑ 10 log �𝜎𝜎� 𝑥𝑥�𝑖𝑖(𝑛𝑛)�2
𝜎𝜎
� 𝑛𝑛�𝑖𝑖(𝑛𝑛)�2 �𝑣𝑣𝑖𝑖=1  (13) 
Table 4.1 shows the estimated averages of NFs and SNRs corresponding to the spectral 
subtraction, LMS, sign LMS, normalized LMS and fast block LMS algorithms respectively.  
Lower value of the estimated NF and higher value of estimated SNR are indicative of greater 
proportion of noise being removed. Hence in comparison, the algorithm that provides a lowest 
value of NF and a highest value of SNR is considered to be performing better. 
Table 4.1: Estimated Average NFs and SNRs.  
Noise Cancellation  NF(dB) SNR(dB) 
Spectral Subtraction 20.54 -8.16 
LMS 25.43 -9.75 
Sign LMS 22.46 -8.48 
Normalized LMS 25.12 -9.76 
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Table 4.1 (Contd.). 
Fast Block LMS 25.38 -9.20 
After application of spectral subtraction, Ptotal shows an average estimated SNR of -8.16 
dB. Figure 4.5a shows the noisy measurement that was recorded at a critical care setting using the 
G.R.A.S 46 AD microphone. The noisy data is corrupted mainly due to acoustical artifacts 
generated from background speech, critical and emergency care instruments such as mechanical 
ventilator and the patient monitors. Specifically, it was observed that a very low frequency periodic 
noise due to a combination of hissing and thumping sounds was generated by the mechanical 
ventilator. This periodic artifact left a significant impact on the SNR of the measurement which 
can be seen around 10 and 50 seconds in Figure 4.5a. Spectral subtraction also provided 
considerable attenuation to the artifacts (see Figure 4.5b).  On the other hand, the average estimated 
SNR of Ptotal after adaptive noise cancellation based on LMS and sign LMS were found to be -9.75 
and -8.48 dBs, respectively.  Figures 4.5c and 4.5d show the resultant outputs of LMS and sign 
LMS.  With respect to normalized LMS and fast block LMS, the post noise cancellation average 
estimated SNR were found to be -9.76 and -9.20 dBs, respectively. Specifically, normalized LMS 
and fast block LMS have not provided considerable artifact attenuation in comparison to other 
noise cancellation techniques. See Figures 4.5e and 4.5f.  
Though sign LMS quantitatively provides almost similar performance to that of spectral 
subtraction, spectral subtraction outperformed the sign LMS in attenuating the artifacts and 
providing better estimates of NF and SNR especially in the periods of d(n) where the artifact is not 
present. Thus, it was concluded that the spectral subtraction provides efficient performance in 
estimating x(n) from d(n) compared to the LMS, sign LMS, normalized LMS and fast block LMS 
algorithms. 
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Figure 4.5a: Noisy Measurement. Figure 4.5b:  SNR Enhanced Signal Using Spectral Subtraction. 
  
Figure 4.5c: SNR Enhanced Signal Using 
LMS Based ANC. 
Figure 4.5d: SNR Enhanced Signal Using 
Sign LMS Based ANC. 
  
Figure 4.5e:  SNR Enhanced Signal Using 
Normalized LMS Based ANC. 
Figure 4.5f: SNR Enhanced Signal Using 
Block LMS Based ANC. 
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4.2.2 Source Separation 
The noise reduced signal is then processed using the source separation block. This single 
channel observation is decomposed into various levels using discrete wavelet transform where 
only vital bio-signals of interest are then hard thresholded and reconstructed back. The details of 
these blocks of source separation are described in the following subsection. 
4.2.2.1 Wavelet Based Source Separation 
Preliminary results of Hashiodani et al. [73] indicated that analyzing the sounds acquired 
from an arterial body site can potentially include information with respect to bio-signals like heart 
sounds, sounds of blood stream, and respiratory sounds. As a result, it was assumed that the 
analysis of enhanced Pdynamic, i.e., sound of blood flow, would provide information with respect to 
bio-signals like heart and respiratory sounds.  In this context, studies [74, 75] that used time-
frequency transformation techniques to localize heart sounds from respiratory sounds have shown 
promising results especially for single channel source separation.  Therefore, in this study a 
wavelet based MRA has been implemented in order to unmask the underlying bio-signals.  In 
MRA, the given signal 𝑥𝑥�(𝑛𝑛), i.e., SNR enhanced Pdynamic is decomposed into various levels of 
approximation (A) and detail (D) coefficients according to equation (14). 
𝐴𝐴𝑚𝑚(𝑛𝑛)  = < 𝑥𝑥�(𝑛𝑛),𝜑𝜑𝑚𝑚𝑚𝑚(𝑛𝑛) > 
(14) 𝐷𝐷𝑚𝑚(𝑛𝑛)  = < 𝑥𝑥�(𝑛𝑛),𝜓𝜓𝑚𝑚𝑚𝑚(𝑛𝑛) > 
where <.> operator represents inner product, m represents the decomposition level, k represents 
the translation, 𝜓𝜓 represents the mother wavelet with R vanishing moments and 𝜑𝜑 corresponds to 
its scaling function.  In order to obtain the approximations and details of the subsequent levels, the 
wavelet (𝜓𝜓) and scaling (𝜑𝜑) functions are represented as recursive functions given in equation (15) 
[76]. 
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𝜓𝜓(n) = ∑
∞
−∞=p
h(p)  𝜑𝜑(2n – p) 
(15) 
𝜑𝜑(n) = ∑
∞
−∞=p
g(p)  𝜑𝜑(2n – p) 
In equation (15), h(p) and g(p) are impulse responses of low pass and high pass quadrature 
mirror filters, respectively. The approximation and detail coefficients at each level are a result of 
the convolution between the signal 𝑥𝑥�(𝑛𝑛) with the impulse responses of h(p) and g(p).  The 
approximation coefficients obtained at each level are down sampled by a factor of two and 
decomposed further into finer approximations and details.  This process was continued until all 
the levels of the MRA were reached.  After all the approximation and detail coefficients were 
obtained from the MRA, the coefficients corresponding to all the scales were set to zero except for 
the coefficients of the interest in a particular level.  This hard thresholding process has been 
adopted in this current study to unmask bio-signals in the wavelet domain.  Finally, after 
application of the thresholding, the new coefficients were reconstructed back into the time domain.  
Both the acoustic heart and respiratory pulses exhibit a different behavior in the wavelet domain 
in the sense that the acoustic heart pulses are highly dynamic and non-stationary; on the other hand, 
acoustic respiratory pulse is relatively slow varying [75]. Therefore, the chosen mother wavelet 
(𝜓𝜓) should provide a reasonably good low and high frequency resolution to the underlying bio-
signals of 𝑥𝑥�(𝑛𝑛) through compact support.  Additionally, the lower cutoff frequency of the pressure 
field microphone was set to 3.15 Hz.  Therefore, any underlying bio-signals of interest that 
contained frequency components below 3.15 Hz would have been attenuated and appeared as 
discontinuities in the measured pressure data.  As a result, the chosen 𝜓𝜓 need to be able to detect 
the presence of hidden discontinuities.  Finally, the 𝜓𝜓 should be orthogonal to avoid phase 
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distortions from the transformation.  All the requirements of the current study were satisfied by 
the Coiflet wavelet with four vanishing moments. 
4.2.2.2 Results of Source Separation 
The estimate 𝑥𝑥�(𝑛𝑛) from spectral subtraction was subjected to MRA using fourth order 
Coiflet wavelet.  The level of decomposition at which the detail coefficients were retained was 
bio-signal dependent and thus for acoustic heart pulses the coefficients of interest were identified 
at level four and for acoustic respiratory pulses the coefficients of interest were identified at level 
ten.  Following the ten level MRA decomposition, coefficients of interest in a particular level were 
retained and a hard threshold was applied to coefficients corresponding to other scales.  The 
acoustic heart and respiratory pulses masked in 𝑥𝑥�(𝑛𝑛) were extracted by performing a hard 
threshold on MRA coefficients, simultaneously retaining details coefficients of level four (D4), 
level ten (D10) and reconstructing them individually back into the time domain. Figures 4.6a and 
4.6b show the extracted acoustic heart and respiratory pulses obtained after reconstruction. 
 
Figure 4.6a: Extracted Acoustic Heart Pulses.  
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Figure 4.6b: Extracted Acoustic Respiratory Pulses. 
The acoustic heart pulses were benchmarked by computing average heart rate in beats per 
minute (bpm) and comparing it to the average of heart rate that was recorded prior and post-
acquisition of the noisy measurement.  Since the acoustic respiratory pulse is a slowly varying 
waveform, further analysis was done on a relatively large time period.  A first order sample 
difference was computed in order to identify the presence of any discontinuities that may have 
been present due to the bandlimited frequency response of the pressure field microphone. The 
corresponding results are shown in Figure 4.7. 
From Figure 4.7, it can be observed that the slow moving respiratory signal was attenuated 
and discontinuities were introduced due to this attenuation. The number of discontinuities present 
were in direct correlation to the average respiratory rate in breaths per minute (rpm) acquired prior 
and post the d(n) acquisition for the purpose of benchmarking. The discontinuities can also be 
identified using MRA. The extracted acoustic respiratory pulse was decomposed into first level 
approximation and detail coefficients using fourth order Coiflet wavelet to obtain similar results. 
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Figure 4.7: Acoustic Respiratory Pulse and the Corresponding Discontinuities. 
4.2.2.3 Validation 
Table 4.2 presents the error analysis results of computed heart and respiratory rates 
benchmarked with modalities obtained using conventional devices for all the venous and arterial 
blood flow dynamics given in Table 3.1. 
Table 4.2: Error Analysis Results of Heart Rate and Respiratory Rate Benchmarking. 
Index 
Heart Rate (bpm) Respiratory Rate (rpm) 
Recorded 
Value 
Computed 
Value 
Error 
(± %) 
Recorded 
Value 
Computed 
Value 
Error 
(± %) 
1a 95 99 
3.78 
10 10.5 
5 5a 110.5 102 10 10 
6a 128 120 10 11 
1b 218 210 
0.59  
10 11.5 
15 5b 216.5 217.5 10 11.5 
6b 222 225 10 11.5 
2b 108.5 105 
1.87 
10 11 
13 3a 116 112.5 10 11.5 
4b 96.5 97.5 10 11.5 
2a 179 180 
2.38 
10 10 
5 3b 200 195 10 11 
4a 204.5 194.6 10 10.5 
The error percentage computed by benchmarking with conventionally measured modalities 
validate the extracted acoustic heart and respiratory pulses.  From Table 4.2, it was observed that 
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the novel catheter multiscope measures the heart rate with an estimated error less than 4%, i.e., 
with higher precision when compared to the current heart rate monitors [77].  With respect to the 
respiratory rate, the proposed catheter multiscope recorded the largest estimation error of 15% (1.5 
rpm), which is within the acceptable tolerance and can be regarded as a comparable measurement 
to an optimized respiratory rate monitor [78]. 
4.3 Continuous Blood Pressure Computation Framework 
Continuous blood pressure was extracted from Ptotal following a novel signal processing 
framework shown in Figure 4.8.  Even though static pressure was equalized, it was observed that 
measured Ptotal consisted of traces of Pstatic due to the insufficient discharge time constant of the 
pressure field microphone.  Making use of this limitation, normalized blood pressure was 
extracted, i.e., Pstatic was extracted by computing the local mean for every 25 ms from the measured 
Ptotal.  This local mean computation effectively compressed the number of data samples of Ptotal 
from 10000 samples to 40 samples for each second.  The segment length for mean computation 
was deliberately chosen to be 25 ms since all the harmonics of blood pressure signal are present 
between 0 to 20 Hz.  Extraction of Pstatic from Ptotal resulted in normalized blood pressure. The 
computed normalized blood pressure was further validated by establishing comparison between 
the human and animal blood pressure data. This comparison was accomplished by estimating the 
magnitude squared coherence between the normalized blood pressure data derived from recording 
index 1a and the Physionet arterial blood pressure derived from a mutli-parameter waveform 
database using Welch’s overlapped segment averaging.  
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Figure 4.8: Overview of Continuous Blood Pressure Computation Framework. 
4.3.1 Blood Pressure Estimation and Validation 
From the extracted normalized blood pressure, it is not possible to directly estimate the 
systolic and diastolic pressure. To estimate pressures, the pressure field microphone attenuation 
factors k1, k2 corresponding to systolic and diastolic pressures were first estimated using the 
regression model shown in equation (16), where sys is the systolic pressure, dia is the diastolic 
pressure, M is the mean arterial pressure obtained using the conventional devices, P is the local 
maxima and V is the local minima of the normalized blood pressure obtained after compression of 
Ptotal. k1 and k2 are the sensor attenuation factors corresponding to the systolic and the diastolic 
pressures. 
sys = k1 . (P + M) (16) dia = k2 . (V + M) 
The regression model first estimates the systolic and diastolic attenuation factors using the 
blood pressure data obtained from conventional instruments, i.e., M, sys and dia.  The systolic and 
diastolic pressures were then estimated using the computed regression model.  The sensor 
attenuation factors k1 and k2 were computed using the normalized blood pressure data for recording 
indices 1a to 6b.  The factors k1 and k2 were found to be 1.1078 ± 0.0658 and 0.8854 ± 0.0449, 
respectively.  Later, the mean values of the obtained k1 and k2 are used to compute average systolic 
and diastolic pressures using equation (16) for all the recording indices from 1a to 6b as shown in 
Table 4.3. 
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Table 4.3: Error Analysis Results of Systolic and Diastolic Pressures Benchmarking. 
Recording 
Index 
Systolic Pressure (mmHg) Diastolic Pressure (mmHg) 
Recorded 
Value 
Computed 
Value 
Error 
(± %) 
Recorded 
Value 
Computed 
Value 
Error 
(± %) 
1a 84.5 82.5 
3 
63 65.96 
1.5 5a 45 41 31.5 32.6 
6a 39 39.9 34 31.9 
1b 189.5 196.6 
5 
152.5 157.2 
1.9 5b 181 187.8 152.5 150.1 
6b 141 152.9 133 122.2 
2b 52.5 49.9 
5.6 
39 39.8 
4.2 3a 44.5 42.1 30.5 33.6 
4b 51 47.6 37.5 38.1 
2a 124 135.7 
4.1 
110 108.5 
2.4 3b 171.5 175.6 143 140.3 
4a 186.5 190.5 158 152.3 
From Table 4.3, it can be observed that the novel catheter multiscope is able to predict 
systolic pressures with an estimated average error rate less than 6% and diastolic pressures with 
an estimated average error rate less than 5% in comparison to the current gold standard.  It should 
be noted that, at this point results obtained for continuous blood pressure are considered to be 
preliminary since the systolic and diastolic pressures have been approximated from a sensor 
attenuation factor model. Additional benchmarking was accomplished with a human blood 
pressure data to confirm the validity of described blood pressure estimation approach. Details are 
provided in Appendix A. 
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CHAPTER 5: APPLICATION CASE STUDIES 
 
5.1 Sinus Rhythm Pattern Recognition3. 
5.1.1 Background 
The centers for disease control and prevention estimates that more than 600,000 people die 
of heart diseases every year in United States [79]. In addition to this overwhelming number of 
heart disease cases, critical care units in the United States have reported a 90% false arrhythmia 
alarm rate. Blood pressure, heart and respiratory rates are among other vital bio-signals that are 
acquired and monitored in critical care units [80]. No other comparable studies in the literature 
have described a diagnostic system that is capable of providing multiple vital bio-signals and 
detecting an arrhythmia. Hence, our motivation is to develop a multiple bio-signal feature 
extraction and pattern recognition framework for biomedical acoustic signals. In order to 
demonstrate the feasibility of the developed framework, preliminary results are presented by 
processing the acoustic heart pulses of the catheter multiscope  
The blood flow sounds collected from various body sites in the current case study under 
the conditions of normal and abnormal sinus rhythms are analyzed using an extended version of 
the previously validated signal processing framework. See Figure 4.2. The extended framework, 
initially extracts the acoustic heart and respiratory pulses from the measured blood flow sounds  
  
                                                          
3A preliminary version of the content presented in Chapter 5, section 5 has been published in proceedings of 2017 
International Conference of Software and Smart Convergence [125] and NIH-IEEE 2017 Special Topics conference 
on Healthcare Innovations and Point of Care Technologies: Technology in Translation [124]. 
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using a noise cancellation and wavelet source separation technique based preprocessing. Then, the 
extracted acoustic heart pulses are post processed to recognize the patterns of the sinus rhythm 
based on a novel feature extraction technique and cluster analysis. The developed framework was 
qualitatively and quantitatively validated by providing visual results of the clustering and by 
computing the clustering accuracy, sensitivity and specificity. The cross validation results show 
that the developed framework consistently recognizes the patterns of the sinus rhythms with an 
accuracy rate of 94.37%. 
5.1.2 Pattern Recognition Framework 
Analysis and processing of the acquired dynamic pressure, i.e., blood flow sounds, was 
viewed as a problem that requires a combination of preprocessing, feature extraction and 
clustering. Since the measurement was made in a noisy clinical setting, measurement of this blood 
flow sound was interfered by other acoustical sources present in the setting. Thus, in order to 
extract the bio-signals with fidelity from this measurement, noise had to be reduced using a spectral 
subtraction based noise cancellation technique. Next, the noise reduced signal was preprocessed 
with the wavelet source separation in order to extract acoustic heart and respiratory pulses. Later 
the extracted acoustic heart pulses were segmented; features were extracted and the pattern was 
then recognized from the extracted features. The developed feature extraction and pattern 
recognition technique was able to independently cluster normal and abnormal sinus rhythm 
patterns of the acoustic heart pulses. Figure 5.1 shows the developed signal analysis and processing 
framework for biomedical acoustic signals. The acoustic heart pulses obtained by processing the 
signals of the catheter multiscope, as described in section 4.2 were processed further through 
feature extraction and pattern recognition. The features multiscale energy was extracted and then 
its pattern was recognized using K-Means clustering as explained in the following sections. 
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Figure 5.1: Biomedical Acoustical Signal Analysis and Processing Framework. 
5.1.2.1 Feature Extraction and Cluster Analysis 
5.1.2.1.1 Multiscale Energy 
A Continuous Time Wavelet Transform (CTWT) based feature called multiscale energy 
was developed and computed for each segment of the acoustic heart pulse. The normalized CTWT 
of a continuous signal h(t) is given by equation (17). 
Wh;𝜓𝜓(τ, s)    =  1
√s� h(t) ∗ 𝜓𝜓∗ �t − τs �dt                     ∞−∞  (17) 
Here W is the computed continuous wavelet transform, h(t) is a segment of the acoustic 
heart pulse, s is the scale coefficient associated to stretching or compression of the signal in time, 
τ is the translation parameter, 𝜓𝜓 is the chosen mother wavelet [81]. The Multiscale Energy (ME) 
is computed using equation (18).  
𝑀𝑀𝑀𝑀(𝑠𝑠) =  �� Wh;𝜓𝜓(τ, s)�2
𝜏𝜏
 (18) 
The ME feature is computed at each scale of the CTWT of h(t) using Coiflet wavelet with 
four vanishing moments as chosen mother wavelet. 
5.1.2.1.2 K-Means Clustering 
K-means clustering algorithm was applied to ME features of the acoustic heart pulse 
segments for sinus rhythm pattern recognition. The following procedure adapted from [82] is 
implemented to cluster the ME features: 
1. Input the computed ME feature vector set, v, of the extracted acoustic heart pulses to K-
Means algorithm. 
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2. Randomly select the initial cluster centers from the feature set whose dimension is nb1 x 
nb2 x np x fp. Here, nb1 represents the number of body sites, nb2 is the number measurements 
taken at each body site, np is the number of segments and fp represents the number of 
features per segment or feature index, i.e., features computed based on the scale vector of 
the CTWT.  
3. Assign the features that are closest to the cluster centroids according to the Euclidean 
distance function shown in equation (19) to the cluster number (j) depending on the 
maximum number of clusters, K, and nb1 x nb2 x np. 
� � �𝑣𝑣𝑝𝑝
𝑗𝑗 −  𝑐𝑐𝑗𝑗�2𝑛𝑛𝑏𝑏1 × 𝑛𝑛𝑏𝑏2 × 𝑛𝑛𝑝𝑝
𝑝𝑝=1
𝐾𝐾
𝑗𝑗=1
 (19) 
4. Recompute the centroids based on the formed new clusters.  
5. Iteratively repeat the steps 2, 3 and 4 until the Euclidean distance function reaches 
convergence. 
5.1.3 Results and Discussion 
After preprocessing the blood flow sounds, further analysis was done on the extracted 
acoustic heart pulses corresponding to normal and abnormal sinus rhythms. The extracted acoustic 
heart pulses were segmented into three second long segments and the ME features were computed 
for each segment of the acoustic heart pulses. It has to be noted that, the number of body sites is 
 
Figure 5.2: Feature Extraction and Pattern Recognition Dimensionality. 
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2; the number of measurements at each body site, nb2, is 2; the number of segment instances, np, is 
40 and the number of features per segment, fp, is 116.  Figure 5.2 is provided to show the 
dimensionality of the data when feature extraction and pattern recognition is performed. 
Also, prior clustering, features corresponding to different body sites and sinus rhythm 
patterns were randomly grouped to obtain a final feature set with dimensions resulting in (2 x 2 x 
40) x 116, where 2 x 2 x 40 is the segment index corresponding to acoustic heart pulses of both 
normal and abnormal sinus rhythms of carotid artery and jugular vein. Figures 5.3a and 5.3b show 
the ME features computed for acoustic heart sounds of normal and abnormal sinus rhythm 
segments of the carotid artery. In Figures 5.3a and 5.3b, each color represents the features (1x116) 
per segment. Figures 5.3a and 5.3b show the ME features computed for acoustic heart sounds of 
normal and abnormal sinus rhythm segments of the carotid artery. In Figures 5.3a and 5.3b, each 
color represents the features (1x116) per segment.  
The computed ME features are scaled and separated into 2 clusters using Euclidean 
distance based K-means clustering algorithm. The cluster number (K) has been selected based on 
the average silhouette coefficient (Cp) computation given in [83]. The Cp for the data used in the 
 
Figure 5.3a: ME of Acoustic Heart Pulse Corresponding to Normal Sinus Rhythm. 
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current case study was determined to be 2 which can be associated to clusters corresponding to 
normal and abnormal sinus rhythms. Figure 5.4 shows the qualitative results of K-means 
clustering. 
 
Figure 5.4: Qualitative Results of K–Means Clustering. 
It can be observed from Figure 5.4 that K-means provides a satisfactory sinus rhythm 
pattern recognition by separating the ME features into two different clusters. To further validate 
 
Figure 5.3b: ME of Acoustic Heart Pulse Corresponding to Abnormal Sinus 
Rhythm. 
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the developed ME features and the clustering framework, quantitative factors such as sensitivity, 
specificity and accuracy have been computed from a cross validation based confusion matrix. 
Cross validation was accomplished by mixing the final feature set and performing clustering on 
the mixed feature set. It has to be noted that the clustering was accomplished by randomizing the 
feature set mixture up to 10 times. Finally, average values of the quantitative factors of the 
confusion matrix were computed. Table 5.1 presents the averaged results of the confusion matrix 
of the cluster analysis. 
Table 5.1: Confusion Matrix of the Cluster Analysis. 
np = 160 Sinus Rhythm: Normal Sinus Rhythm: Abnormal 
Predicted: Normal Sinus 
Rhythm TN = 73 FN = 2 
Predicted: Abnormal 
Sinus Rhythm FP = 7 TP = 78 
The confusion matrix shown in Table 5.1 was computed for 160 segment instances. The 
segment instances corresponding to the normal sinus rhythm was defined as True Negative (TN), 
i.e., cluster number 0 and the abnormal sinus rhythm was defined as True Positive (TP), i.e., cluster 
number 1. Sensitivity and specificity were computed from Table 2 to show that the developed 
framework recognizes the patterns of the normal sinus rhythm with 91.25% precision and 
abnormal sinus rhythm with 97.5% precision. In addition, it was also noted that the overall ability 
of the developed framework in recognizing the patterns of the sinus rhythms was accurate to 
94.37%. 
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5.2 Fetal Phonocardiography4 
5.2.1 Background 
The Centers for Disease Control and Prevention (CDC) estimates that more than one 
million fetal deaths occur in the United States per year [84]. Complications such as preterm 
delivery, hypoxia, intrauterine growth retardation and others, not only lead to fetal distress and 
neonatal death but also can cause risks to maternal health. There is a lesser knowledge about the 
incidence, etiology and prevention strategies for these complications; therefore it is critical to 
monitor the status of both fetal and maternal health throughout pregnancy. Consequently, 
Electronic Fetal Monitoring (EFM) was introduced in 1960s as a valuable tool for diagnosing Fetal 
Heart Rate (FHR) during the antepartum and intrapartum periods of pregnancy [85].  Today, EFM 
is used in 90% of the labor diagnosis procedures in the United States [86] and includes 
Electrocardiography (ECG), Phonocardiography (PCG), Pulse Oximetry, Magnetocardiogram 
(MCG) and Tocodynamometer. Organizations such as the International Federation of Gynecology 
and Obstetrics (FIGO), the American College of Obstetricians and Gynecologists (ACOG), the 
National Institute of Child Health and Human Development (NICHHD), the Royal College of 
Obstetricians and Gynecologists (RCOG), and the National Institute of Clinical Excellence (NICE) 
have standardized the use of EFM in conjunction with Maternal Uterine Contractions (MUC) 
known as Cardiotocography (CTG) to optimize the outcomes for the mother and the new born 
infant [87, 88].   
Fetal Phonocardiography (FPCG) was discovered by the interventions of Marsac, 
Kergardec and Kennedy during the 17th century [89, 90].  Although FPCG was discovered many 
                                                          
4The contents in chapter 5, section 5.2 have been published in Journal of Biomedical Signal Processing and Control 
[117] and proceedings of 36th Annual International Conference of the IEEE Engineering in Medicine and Biology 
Society [126] 
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years ago, interest in this research has only occurred over the last few years. Currently, the 
application of FPCG is limited to FHR analysis and is seen as a noninvasive means for data 
acquisition; it is only used as a secondary diagnosis tool in the antepartum, and has never been 
utilized for complete clinical diagnosis.  There are few reasons as to why FPCG is not clinically 
accepted for a complete diagnosis:  First, the FPCG is very noisy, owing to the fact that the 
acquired signal is a mixture of fetal acoustic components, maternal acoustic components and many 
other noises. Second, the characteristics of the aforementioned components are highly dependent 
on the location of data acquisition, gestational age, fetal and maternal positions which result in 
signal non-stationarity; finally, the non-linear transmission medium dynamically morphs all the 
components to result in a narrow band signal.  Today’s standard of care in fetal monitoring suspects 
that the fetal heart rate is predictive of pregnancy complications [91].  As a consequence, EFM 
relies predominantly on FHR and does not incorporate the characteristics of the FPCG waveform 
in the assessment of fetal and maternal outcomes.  The primary reason for the exclusion of this 
information from clinical practice is that the technology to measure the Fetal Heart Sounds (FHS) 
reliably is not yet available.  Secondly, the existing signal processing techniques are unable to 
deliver a FHS signal from the acquired FPCG signal without considerable distortion.  
5.2.2 State-of-the-Art in Fetal Monitoring 
The technologies available to accomplish fetal monitoring are FPCG, Fetal Ultrasound, 
Fetal Electrocardiography (FECG) [20, 92], Fetal Magnetocardiography (FMCG) [93], Fetal Pulse 
Oximetry/Photoplethysmography (FPPG) [94] and Tocodynamometer/Intrauterine Pressure 
Catheter (IUPC) [95].  Among all these methods, ultrasound is regarded as the gold standard in 
fetal monitoring and is widely used during pregnancy and labor.  When ultrasound is used to obtain 
biophysical profiles and images, typically during weeks 18 – 22, is known as echocardiography 
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[96]; when ultrasound is used in conjunction with tocodynamometer/IUPC, typically employed 
during labor and antepartum to acquire FHR and UC, is known as cardiotocography (CTG) [97].  
Continuous fetal monitoring using ultrasound, particularly during labor, is highly challenging for 
two main reasons: the transducer of the ultrasound’s data acquisition system needs frequent 
realignment, and the constant presence of a highly trained operator during data acquisition is 
required [98, 99].  Ultrasound technique is highly sensitive to movement, hence any maternal and 
or fetal movement is known to affect the ultrasound’s beam reflection [100].  Also, long term and 
ambulatory fetal monitoring using ultrasound is inappropriate due to complexity of the 
instrumentation [100, 101].  Studies [101, 102, 103, 104] have shown that long-term and short-
term variability of FHR obtained from ultrasound data are not as precise when compared to other 
techniques.  Even if all the limitations of the ultrasound technique are rectified, ultrasound still 
exposes the fetus to radiation.  The safety of the fetus from this radiation exposure remains a 
concern, due to the lack of evidence in the current literature [105, 106, 107, 108, 109, 110].  
Besides these limitations, data obtained from FPCG contains more information on cardiac 
abnormalities and pathologies than ultrasound in relation to fetus and mother [111]; hence, the 
consideration of ultrasound as the gold standard is debatable. Most of the fetal cardiac 
abnormalities are believed to have some manifestation on the morphology of the FECG and the 
FMCG.  However, they exhibit a poor Signal to Noise Ratio (SNR) due to unresolved maternal 
and bio-signal interferences [102, 103] and they have a complex instrumentation [102, 112, 113].  
Traditionally, FECG is known for producing the highest quality measurement of FHR, but it has 
been shown within the literature that FHR from a FPCG signal is equally as reliable as FECG 
[114].  The use of FPPG is also restrained, as the light emitted from the signal is known to increase 
the fetal temperature, has a poor SNR due to the presence of ambient light and it has an optical 
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shunt problem [115].  Henceforth, the current standards of fetal monitoring are unreliable 
particularly during labor [116, 19].  On the other hand, though the FPCG has potential for fetal 
monitoring during first and second trimesters as well as labor, its usage as a secondary diagnosis 
tool is limited to antepartum as it suffers from low SNR due to maternal signal interference, 
maternal motion, nonlinear transmission medium and limitations in the existing data acquisition 
approaches and data acquisition systems.  If the existing data acquisition approaches, data 
acquisition systems and signal processing techniques are improved, FPCG is capable of addressing 
all the limitations that the other methods present.  Based on this observation, motivation for 
addressing the gaps of fetal monitoring through FPCG was found. 
Acquisition, analysis, and processing of fetal heart sounds from maternal body is known 
as FPCG.  The signal acquired at the transducer is a superimposition of various time varying 
acoustic and pressure components.  Essentially it consists of fetal acoustic and pressure 
components: Fetal Heart Sounds (FHS), Fetal Movements (FM) that include Fetal Respiration 
(FR), fetal hiccups, and body movements; maternal acoustic and pressure components: Maternal 
Heart Sounds (MHS), Maternal Organ Sounds (MOS) that include Maternal Respiration (MR), 
Maternal Uterine Contractions (MUC), Maternal Digestive Sounds (MDS), and Maternal Motion 
(MM); additional signal components that include Power Line Interference (PLI), Reverberation 
Noise (RN), Sensor and Background Noise (SBN).  These components provide invaluable 
diagnostic information about the fetal and the maternal health; however, its analysis and processing 
is rather challenging.  In particular, the FHS signal has low SNR as it gets attenuated due to 
transmission path losses, and also gets superimposed with other fetal, maternal and additional 
components.  Among all the components of FPCG, MHS overlap with FHS in both time and 
frequency domains.  Further, fetal position, maternal obesity, placental position and location of 
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data acquisition play an important role in determining the SNR of the FHS signal and henceforth 
the SNR of the FPCG.  For these reasons, denoising and recovering FHS from FPCG requires 
application of advanced signal processing algorithms.  
In the literature, various signal processing techniques have been described to denoise the 
FPCG ranging from simple digital filters to advanced source separation techniques [117].  Though 
filtering and other heuristic methods are computationally efficient, these methods are not able to 
completely reduce the MHS interference in FPCG. Consequently, to solve the problem of MHS 
interference, adaptive filtering and blind source separation techniques have been implemented.  
However, these techniques require data that is captured from multiple channels in order to 
successfully denoise the MHS from FPCG and thus when it comes to single channel FPCG, these 
techniques do not perform well.  Though specific blind source separation techniques have also 
been used to decompose FHS from a single channel FPCG, they fail to successfully retain time 
domain characteristics of the FHS, in particular FHR.  In summary, the proposed techniques suffer 
to efficiently eliminate both the in-band and out-of-band noise present within a single channel 
FPCG. 
In order to address these challenges, a single channel FPCG processing framework has 
been developed. This framework is capable of denoising the FPCG by accurately reconstructing 
FHS while efficiently removing the MHS and out-of-band interferences.  The proposed framework 
first enhances the SNR of the noisy FPCG by removing the out-of-band noise using a single 
channel enhanced spectral subtraction technique.  The performance of the implemented denoising 
algorithm is quantitatively assessed by computing Noise Factor (NF).  Then, the SNR enhanced 
FPCG is decomposed into FHS and MHS in time-scale domain using a wavelet based source 
separation as shown for the catheter stethoscope in Figure 4.2.  Finally, the recovered FHS and 
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MHS are quantitatively validated by computing FHR, Maternal Heart Rate (MHR) and comparing 
it to the standard values. 
5.2.3 Fetal Phonocardiogram Processing Framework 
Analysis and processing of a single channel FPCG signal was seen as a problem that 
requires a combination of noise cancellation and source separation for noise reduction and bio-
signal interference resolution.  The noise reduction technique was predominantly used to remove 
the out-of-band noise such as fetal movements, maternal organ sounds and additional components 
and in order to enhance the SNR of the noisy FPCG signal. A wavelet based source separation was 
implemented to decouple the MHS from FPCG, i.e., the in-band noise in order faithfully recover 
FHS.  Figure 5.5 illustrates the framework that was used to process the single channel FPCG data. 
The simulated fetal phonocardiogram signals are processed using similar noise cancellation and 
source separation algorithms described earlier in section 4.2 and as shown in the block diagram in 
Figure 5.5. The framework was validated using the simulated FPCG dataset extracted from the 
PhysioNet database [118] [25].  Single channel FPCG signals corresponding to various SNR 
conditions were subjected to the developed framework to assess its reliability. 
 
Figure 5.5: Fetal Phonocardiogram Processing Framework. 
5.2.3.1 Noise Cancellation  
In this case study, an enhanced spectral magnitude subtraction technique was implemented 
to remove the out-of-band noise superimposed onto the FPCG.  Fetal movements, maternal organ 
sounds and additional components are the major contributors of the out-of-band noise.  In the 
simulated FPCG dataset, the impulse responses of the out-of-band noise were identified to be either 
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Gaussian or impulse noise.  In particular, MDS, MR, FM and SBN were the sources of the 
Gaussian noise; MM and RN were the sources of the impulse noise.  The out-of-band noise is 
estimated and updated from the periods when the FHS and MHS are absent. 
The implemented spectral subtraction algorithm includes a data channel that consists of 
noisy FPCG data, d(n), and a noise channel that estimates an ensemble average of the out-of-band  
from the data channel, n(n).  The d(n) and the n(n) were passed through an initialization block that 
segmented to frames of length one second with 60% overlap between adjacent frames.  Each data 
frame, di(n), and noise frame, ni(n), where i is the frame index and n is the sample index, was 
windowed using a rectangular window and transformed into frequency domain using Discrete 
Fourier Transform (DFT). Then each incoming frequency transformed data frame, Di(f), and noise 
frame, Ni(f), was subjected to magnitude spectral subtraction to provide an estimate of SNR 
enhanced FPCG signal, �𝑋𝑋�𝑖𝑖(𝑓𝑓)�, as shown in equation (5). Then the estimated signal is post 
processed using equation (6) to remove nulls in the spectral domains before performing inverse 
DFT. 
5.2.3.2 Source Separation 
In this case study, a wavelet based Multiresolution Analysis (MRA) has been implemented 
in order to extract the FHS and MHS from the FPCG.  In MRA, the given signal, 𝑥𝑥�(𝑛𝑛), i.e., SNR 
enhanced FPCG is decomposed into various levels of approximation and detail coefficients.  The 
approximation and detail coefficients obtained after the MRA were hard thresholded based on the 
bio-signal of interest and reconstructed back into time domain.  The chosen mother wavelet should 
provide a reasonably good frequency resolution to FHS and MHS, through compact support.  The 
mother wavelet needs to be able to detect the presence of hidden discontinuities.  In addition, the 
wavelet should also be orthogonal to avoid phase distortions from the transformation. All the 
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requirements of the current case study were satisfied by the Coiflet wavelet with five vanishing 
moments.  In addition, qualitative correlation between Coiflet-5 wavelet and the heart sounds, fetal 
and maternal, is very high. 
5.2.4 Results and Discussion 
In order to assess the performance of the developed noise cancellation algorithm, simulated 
FPCG data corresponding to various SNRs were quantitatively evaluated using NF after noise 
cancellation.  Unavailability of the actual out-of-band noise n(n), FHS and MHS data was the main 
reason behind choosing NF as a performance evaluation metric. In this case study, average NF was 
estimated as ratio of variances of d(n) and 𝑥𝑥�(𝑛𝑛). It has to be noted that d(n) and 𝑥𝑥�(𝑛𝑛) were 
segmented into frames of length one second and with 60% overlap between adjacent frames, where 
i and v represent frame index, and number of frames before estimating the average NF as given in 
equation (12). Table 5.2 shows the noise removal consistency of the developed noise cancellation 
algorithm for various SNRs of the simulated FPCG data. Lower value of the NF indicates great 
proportion of noise being removed. 
Table 5.2: Estimated Average Noise Factors for FPCG. 
Standard Deviation of FPCG 
Noise (dB) 
Noise Factor 
(dB) 
73.12 -4.20 
74.76 -3.28 
75.86 -2.41 
76.42 -2.01 
81.81 -0.97 
From Table 5.2, it can be seen that the developed noise cancellation algorithm consistently 
cancels the noise out from the FPCG even under conditions of increasing noise power. Post noise 
cancellation, the estimate 𝑥𝑥�(𝑛𝑛) was subjected to a six level MRA using fifth order Coiflet wavelet.  
The FHS and MHS were extracted as independent sources by performing a hard threshold on MRA 
coefficients, simultaneously retaining details and approximation coefficients of level six (D6 and 
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A6) and reconstructing them individually back into time domain. Figures 5.6.A1, 5.6.A2, 5.6.B1, 
5.6.B2, 5.6.C1 and 5.6.C2 show the noisy signal with noise powers 73.12, 76.42, 81.81 dBs and 
the corresponding FHS and MHS signals obtained after MRA decomposition for six seconds of 
SNR enhanced FPCG, respectively. 
 
Figure 5.6: Noisy FPCG, Separated FHS and Separated MHS Corresponding to Various FPCG 
Noise Powers. 
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From Figures 5.6.A1 – 5.6.C2, it can be observed that, qualitatively the developed 
framework effectively attenuated the out-of-band noises and efficiently resolved the FHS and 
MHS interference from a single channel FPCG.  However, in order to provide additional 
validation, mean Fetal and Maternal Heart Rates (FHR, MHR) along with their standard deviations 
(SD) were computed in beats per minute (bpm) for the analyzed FPCG dataset. Table 5.3 presents 
the results of the estimated FHR and MHR. 
Table 5.3: Estimated FHR and MHR. 
Standard Deviation of FPCG Noise (dB) FHR±SD (bpm) MHR±SD (bpm) 
73.12 143±16 74±4 
74.76 149±25 72±8 
75.86 154±32 71±10 
76.42 150±25 76±20 
81.81 167±36 83±16 
From Table 5.3, it can be seen that the estimated FHR and MHR fall within normal 
range, i.e., 110-210 bpm for FHS and 70-90 bpm for MHS [117]. 
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CHAPTER 6: CONCLUSIONS AND FUTURE RESEARCH 
 
6.1 Conclusions 
Existing critical and emergency care blood flow based data acquisition systems are 
currently limited to only measuring continuous blood pressure. Inability to detect sensitive 
dynamic pressure variations and solve the problem of reducing external acoustic noise are the 
primary limiting factors. In addition, the use of multiple monitoring systems such as 12-lead 
electrocardiogram, capnogram, plethysmograph and Foley catheter present a plethora of other 
challenges including complex and expensive infrastructure, lack of functional interoperability and 
diagnostic precision in low resource settings. To address these challenges, a novel first of its kind, 
catheter multiscope was introduced in this research. The results of the proof of concept and the 
feasibility studies described in the dissertation show that the developed minimally invasive novel 
catheter multiscope can be used to measure critical parameters with clinical accuracy. In particular, 
the catheter multiscope is able to uniquely characterize a physiological phenomenon and 
continuously measure critical parameters such as: heart rate, respiratory rate, systolic pressure and 
diastolic pressure validated using small animal models. In comparison to the existing state-of-the-
art, the developed technology exhibits innovation in terms of complexity of the data acquisition 
system, an efficient signal processing framework and an improved applicability for a low resource 
setting. The sensitive dynamic pressure variations within the blood flow were acquired using a 
data acquisition system that is a composed of a fluid coupled catheter, a fluid to air polymeric  
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membrane and an acoustic waveguide housing a pressure field microphone. Since the acquired 
dynamic pressure is severely affected due to other acoustic interferences present in critical and 
emergency care setting, its signal to noise ratio was improved by developing an efficient spectral 
subtraction based noise reduction algorithm. The performance assessment metrics such as noise 
factor and signal to noise ratio quantitatively validated that the developed algorithm provides a 
better performance compared to other state-of-the-art noise cancellation algorithms.  Then, a 
wavelet based source separation algorithm was developed to separate various acoustic sources 
from a single channel observation. Using the novel source separation algorithm, acoustic heart and 
respiratory pulses were extracted from the noise reduced signal. The framework to process the 
acoustic signals of the novel catheter multiscope can be adapted to other single or multi-channel 
acoustic signals with minor or no modifications. 
It was observed that there were no particular standards to validate the results of critical care 
data acquisition systems. Hence, in this dissertation, a procedure to validate and benchmark the 
performance of critical care data acquisition systems has been developed.  The extracted acoustic 
heart and respiratory pulses were quantitatively validated by showing that the estimated average 
errors for the computed heart and respiratory rates were less than 15%.  In addition, continuous 
blood pressure was derived from the measured total pressure by means of a novel signal processing 
framework. The derived systolic and diastolic pressures were quantitatively and qualitatively 
validated by benchmarking with the gold standard measurements and by establishing an additional 
benchmark with Physionet arterial blood pressure data. The estimated average errors for the 
computed systolic and diastolic pressures were less than 6%. Overall, the feasibility study shows 
that the developed novel catheter multiscope can provide multiple critical parameters like heart 
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rate, respiratory rate, systolic and diastolic pressures with clinical accuracy by measuring a 
physiological process. 
In addition to demonstrating the feasibility of the developed catheter multiscope in critical 
and emergency care monitoring, the diagnostic potential of the developed technology has been 
shown in additional applications including sinus rhythm pattern recognition and fetal monitoring 
through phonocardiography. These application case studies are the byproducts of the catheter 
multiscope, i.e., similar or the same data acquisition system and signal processing framework have 
been utilized. The preliminary results show that it is feasible to measure multiple critical 
parameters from a single physiological phenomenon using the catheter multiscope. The 
methodology implemented in this research can be applied for research, development and 
optimization of other catheter based data acquisition systems for monitoring vital bio-signals. In 
conclusion, there is growing interest for disruptive technology like the catheter multiscope in the 
field of medical devices particularly, in critical and emergency care. It is the ultimate goal of this 
research to establish new frontiers in vital bio-signal monitoring for any critical and emergency 
care under any given low resource settings.  
6.2 Future Research 
From the current feasibility study, it was observed that various challenges with respect to 
the data acquisition system, data analysis and benchmarking have to be addressed in order to 
extract all the bio-signals of interest with fidelity. 
6.2.1 Data Acquisition 
With respect to the data acquisition system, the Pstatic was not measured with precision since 
the computed blood pressure waveform indicated the presence of distortions and resulted in an 
attenuated signal. The acoustic respiratory pulse was attenuated and presented as discontinuities 
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in the Ptotal. In order to address the challenges of the data acquisition system, Pstatic needs to be 
measured with a suitable pressure sensor. The frequency response of the Ptotal measuring sensor 
needs to be specified below 1 Hz to sense changes in the infrasonic sound pressures.   
6.2.1.1 Future Design Optimizations 
Though the pressure field microphone measures the dynamic pressures with high 
sensitivity and precision, it requires the use of a waveguide to effectively acquire the dynamic 
pressure. However, in order to comply with the regulations of FDA, the invasive/minimally 
invasive critical care data acquisition systems are only to be designed for one-time use. For these 
reasons, the use of waveguide and pressure field microphone make the data acquisition system 
expensive. Hence, future generation devices will have to be cost effective and designed for one-
time use.  Figure 6.1 shows the next generation design layout of the catheter multiscope that is 
capable of addressing the existing challenges. 
 
Figure 6.1: Next Generation Design Layout for Catheter Multiscope. 
As shown in Figure 6.1, the existing data acquisition system will be retrofitted using 
retrofits 1 and 2. Retrofit 1 contains a MEMS based static pressure sensing element with a custom 
sensor housing designed to estimate fluid pressure. In addition, retrofit 1 also contains a custom 
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designed Y port, through which saline solution and other drugs can be infused. The Y port also 
enables expansion of the monitoring to other critical parameters such as SPO2 and rapid blood 
analysis.  Retrofit 2 contains a polymeric barrier that is used to provide fluid to air coupling and a 
MEMS microphone is fabricated on the barrier. This design of retrofit 2 eliminates the use of 
waveguide and pressure field microphone. In addition to optimizing the data acquisition system 
through retrofitting, computational fluid dynamics simulations will also be performed in future.  
6.2.2 Data Collection and Signal Processing 
With respect to data analysis, artifacts have not been processed and removed from the data 
and hence before performing any analysis, artifacts need to be attenuated. It should also be noted 
that this study did not consider evaluation metrics like mean squared error and computational 
efficiency in assessing the performance of the noise cancellation algorithms which is proposed for 
future research. Though MRA provided satisfactory bio-signal separation, the decomposition 
coefficients in the scales of interest had to be manually identified in the current study and hence it 
would be interesting to further process the MRA coefficients by an unsupervised clustering 
algorithm like K-means, Gaussian Mixture Models, etc.  Though the acoustic heart pulses were 
extracted from the measured Ptotal without any distortion, it needs to be validated towards 
identification of pathology pertaining to the heart sounds. With respect to benchmarking, in the 
current study, additional modalities like respiratory rate and heart rate were noted prior and post 
data acquisition and hence in order to provide an accurate benchmarking these modalities need to 
be recorded electronically along with the Ptotal measurement. Also, the implemented blood pressure 
computation framework needs additional information from the conventional devices. Regarding 
continuous blood pressure, an accurate benchmark needs to be established in order to provide 
conclusive results and this is currently under study. Overall, the current data acquisition and 
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analysis were validated by acquiring vascular pressure measurements from small animal models 
which needs to be extended to humans. 
6.2.3 Application Case Studies  
6.2.3.1 Sinus Rhythm Pattern Recognition 
Analysis presented in this dissertation evaluated the developed cluster analysis framework 
for the data collected from two different body sites. In order to validate the pattern recognition 
framework, the current case study needs to be implemented for data collected from more than two 
body sites and for various statically robust datasets collected from various animal studies. It should 
be noted that the segmentation accomplished prior feature extraction is a key cluster accuracy 
determining factor. In the current case study, the segmentation length has been chosen empirically 
and for the future study the segmentation needs to be defined based on the clustering objective.  In 
order to improve currently obtained recognition accuracy of 94.37% for the developed framework, 
a multimodal framework has to be developed that includes information from other vital bio-signals 
of the catheter multiscope. Additionally, investigating multimodal features from blood pressure, 
acoustic heart and respiratory pulses may also contribute to the accuracy improvement. It is also 
worth noting that the current case study needs to be applied to various cases of pathological 
arrhythmia. Overall, the current data acquisition and cluster analysis framework was validated by 
acquiring vascular pressure measurements from a Yorkshire pig which needs to be extended to 
humans. The end goal is to be able to reduce the false arrhythmia alarm rates of the critical care 
units. In addition, the framework developed for the acoustic heart pulses of the catheter multiscope 
can also be extended and validated for classification of normal and abnormal heart sounds. 
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6.2.3.2 Fetal Monitoring Through Phonocardiography 
Though the developed spectral subtraction algorithm was able to effectively remove the 
out-of-band noise, the noise factor was seen to be reducing across higher noise power ranges.  
Hence, in order to maintain consistent noise factor throughout all the power ranges of noise, the 
noise estimation algorithm within spectral subtraction will need to be improved in the future.  In 
addition, a comparative analysis has to be performed with multiband spectral subtraction and other 
recent denoising techniques.  In this application, the source separation algorithm was able to 
separate FHS and MHS from the simulated FPCG dataset.  However, the proposed framework is 
currently being extended to a clinically collected FPCG dataset.  Also, as a part of this analysis, 
the feasibility of separating additional vital bio-signals corresponding to the fetus and the mother 
is being assessed.  FHR and MHR were manually computed for this case study and in the future 
this computation should be automated and validated against clinically collected cardiotocographs. 
  
74 
 
 
 
 
 
 
 REFERENCES 
 
[1]  Centers for Disease Control and Prevention, "Emergency Department Visits," National 
Center for Health Statistics, 2017. 
[2]  J. Huygh, Y. Peeters, J. Bernards and M. Malbraina, "Hemodynamic Monitoring in the 
Critically Ill: An Overview of Current Cardiac Output Monitoring Methods," F1000 
Research, vol. 5, no. 2855, pp. 1-9, 2016.  
[3]  L. Busse, D. Davison, C. Junker and L. Chawla, "Hemodynamic Monitoring in the Critical 
Care Environment," Advances in Chronic Kidney Disease, vol. 20, no. 1, pp. 21-29, 2013.  
[4]  E. Kipnis, D. Ramsingh, M. Bhargava, E. Dincer, M. Cannesson, A. Broccard, B. Vallet, 
K. Bendjelid and R. Thibault, "Monitoring in the Intensive Care," Critical Care Research 
and Practice, vol. 2012, pp. 1-20, 2012.  
[5]  C. Kuhn and K. Werdan, "Hemodynamic Monitoring," in Surgical Treatment: Evidence-
Based and Problem-Oriented, Munich, W. Zuckschwerdt Verlag GmbH, 2001.  
[6]  S. Balaji, M. Ellenby, J. McNames and B. Goldstein, "Update on Intensive Care ECG and 
Cardiac Event Monitoring," Cardiac Electrophysiology Review, vol. 6, pp. 190-195, 2002.  
[7]  Z. Moussavim, Fundamentals of Respiratory Sounds and Analysis, Morgan & Claypool 
Publishers, 2006.  
[8]  R. Peura, "Blood Pressure And Sound," in Medical Instrumentation Application and 
Design, John Wiley & Sons, Inc., 2010, pp. 293 - 337. 
[9]  I. Moxham, "Physics of Invasive Blood Pressure Monitoring," Southern African Journal of 
Anaesthesia and Analgesia, vol. 9, no. 1, pp. 33 - 38, 2003.  
[10]  A. Van de Louw, C. Cracco, C. Cerf, A. Harf, P. Duvaldestin, P. Lemaire and L. Brochard, 
"Accuracy of Pulse Oximetry in Intensive Care Unit," Intensive Care Medicine, vol. 27, no. 
10, pp. 1606 - 1613, 2001.  
  
  
75 
 
[11]  J. Lefrant, L. Muller, J. Emmanuel, M. Benbabaali, C. Lebris, N. Zeitoun, C. Mari, G. 
Saïssi, J. Ripart and J. Eledjam, "Temperature Measurement in Intensive Care Patients: 
Comparison of Urinary Bladder, Oesophageal, Rectal, Axillary,and Inguinal Methods 
Versus Pulmonary Artery Core Method," Intensive Care Medicine, vol. 29, no. 3, pp. 414 
- 418, 2003.  
[12]  Trauma and Life Support Center, "A Guide Patient For Patient and Family," 2015. [Online]. 
Available: https://www.uwhealth.org/healthfacts/trauma/4310.pdf. 
[13]  A. K. Abbas and R. Baseem, Phonocardiography Signal Processing, Morgan & Claypool 
Publishers, 2009.  
[14]  J. Allen, "Photoplethysmography and its Application in Clinical Physiological 
Measurement," Physiological Measurement, vol. 28, no. 3, pp. 1 - 39, 2007.  
[15]  M. Elgendi, "On the Analysis of Fingertip Photoplethysmogram Signals," Current 
Cardiology Reviews, vol. 8, no. 1, pp. 14-25, 2012.  
[16]  L. Brochard, G. Martin, L. Blanch, P. Pelosi, F. Belda, A. Jubran, L. Gattinoni, J. Mancebo, 
V. Ranieri, J. Richard, D. Gommers, A. Baron, A. Pesenti, S. Jaber, O. Stenqvist and J. 
Vincent, "Clinical Review: Respiratory Monitoring in the ICU - A Consensus of 16," 
Critical Care, vol. 16, no. 2, pp. 1- 14, 2012.  
[17]  M. De Georgia, F. Kaffashi, F. Jacono and K. Loparo, "Information Technology in Critical 
Care: Review of Monitoring and Data Acquisition Systems for Patient Care and Research," 
The Scientific World Journal, vol. 2015, pp. 1-9, 2015.  
[18]  D. Feigal, "Impact of the Regulatory Framework on Medical Device Development and 
Innovation," in Public Health Effectiveness of the FDA 510(k) Clearance Process: 
Balancing Patient Safety and Innovation: Workshop Report, Washington (DC), National 
Academy of Sciences, 2010, p. Appendix D. 
[19]  S. Hart, G. Dileo, A. Weitzenfeld, P. Hipol, M. Sweeney, F. Sinatra and K. Hufford, 
"Electronic Catheter Stethoscope". USA Patent US 20130018267A1, 17 September 2012. 
[20]  R. Sameni and G. Clifford, "A Review of Fetal ECG Signal Processing : Issues and 
Promising Directions," US Natinal Library of Medicine, no. 3, pp. 4 - 20, 2010.  
[21]  A. Ashley E and J. Niebauer, "Chapter 3, Conquering the ECG," in Cardiology Explained, 
London, Remedica, 2004.  
[22]  B. Goldstein, "Intensive Care Unit ECG Monitoring," Cardiac Electrophysiology Review, 
vol. 1, no. 3, pp. 308-310, 1997.  
76 
 
[23]  D. Poulikakos and M. Malik, "Challenges of ECG Monitoring and ECG Interpretation in 
Dialysis Units," Journal of Electrocardiology, vol. 49, no. 6, pp. 855-859, 2016.  
[24]  M. Broszko and C. Stanciu, "Survey of EKG Monitoring Practices: A Necessity or 
Prolonged Nuisance?," The American Journal of Psychiatry Residents’ Journal, vol. 12, 
no. 3, pp. 6-9, 2017.  
[25]  A. Goldberger, L. Amaral, L. Glass, J. Hausdorff, C. Ivanov P, R. Mark, J. Mietus, G. 
Moody, C. Peng and H. Stanley, "Components of a New Research Resource for Complex 
Physiologic Signals," PhysioBank, PhysioToolkit, and PhysioNet, vol. 101, no. 23, pp. 
e215-e220, 2000.  
[26]  X. Ding, N. Zhao, G. Yang, R. Pettigrew, B. Lo, F. Miao, Y. Li, J. Liu and Y. Zhang, 
"Continuous Blood Pressure Measurement From Invasive to Unobtrusive: Celebration of 
200th Birth Anniversary of Carl Ludwig," IEEE Journal Of Biomedical And Health 
Informatics, vol. 20, no. 6, pp. 1455-1465, 2016.  
[27]  J. Webster, The Measurement, Instrumentation and Sensors Handbook, Boca Raton: CRC 
Press, 1999.  
[28]  S. Esper and M. Pinsky, "Arterial Waveform Analysis," Best Practice & Research Clinical 
Anaesthesiology, vol. 28, pp. 363-380, 2014.  
[29]  B. McGhee and M. Bridges, "Monitoring Arterial Blood Pressure: What You May Not 
Know," Critical Care Nurse, vol. 22, no. 2, pp. 60-79, 2002.  
[30]  M. Reems and M. Aumann, "Central Venous Pressure: Principles, Measurement and 
Interpretation," Vetstreet Inc., 2012. 
[31]  U. Gidwani, B. Mohanty and K. Chatterjee, "The Pulmonary Artery Catheter: A Critical 
Reappraisal," Cardiology Clinics, vol. 31, no. 4, pp. 545-565, 2013.  
[32]  M. Hadian and M. Pinsky, "Evidence-Based Review of the Use of the Pulmonary Artery 
Catheter: Impact Data and Complications," Critical Care, vol. 10, no. 3, pp. 1-11, 2006.  
[33]  T. Sugimoto, K. Dohi, M. Tanabe, K. Watanabe, E. Sugiura, S. Nakamori, T. Yamada, K. 
Onishi, M. Nakamura, T. Nobori and M. Ito, "Echocardiographic Estimation of Pulmonary 
Capillary Wedge Pressure Using the Combination of Diastolic Annular and Mitral Inflow 
Velocities," Journal of Echocardiography, vol. 11, no. 1, pp. 1-8, 2013.  
[34]  M. Pozzoli, S. Capomolla, G. Pinna, F. Cobelli and L. Tavazzi, "Doppler Echocardiography 
Reliably Predicts Pulmonary Artery Wedge Pressure in Patients with Chronic Heart Failure 
With and Without Mitral Regurgitation," Journal of the American College of Cardiology, 
vol. 27, no. 4, pp. 883-893, 1996.  
77 
 
[35]  J. Vanoverschelde, A. Robert, A. Gerbaux, X. Michel, C. Hanet and W. Wiins, 
"Noninvasive Estimation of Pulmonary Arterial Wedge Pressure With Doppler l’ransmitral 
Flow Velocity Pattern in Patients With Known Heart Disease," The American Journal Of 
Cardiology, vol. 75, no. 5, pp. 383-389, 1995.  
[36]  J. Welch, P. Ford, R. Teplick and R. Rubsamen, "The Massachusetts General Hospital-
Marquette Foundation Hemodynamic and Electrocardiographic Database - Comprehensive 
collection of critical care waveforms," Journal of Clinical Monitoring, vol. 7, no. 1, pp. 96-
97, 1991.  
[37]  S. Nadeau and W. Noble, "Limitations of Cardiac Output Measurements by 
Thermodilution," Canadian Anaesthetists Society Journal, vol. 33, no. 6, p. 780–784, 1986.  
[38]  J. Huygh, Y. Peeters, J. Bernards and M. Malbrain, "Hemodynamic Monitoring in the 
Critically Ill: An Overview of Current Cardiac Output Monitoring Methods," F1000 
Research, vol. 5, no. 2855, pp. 1-9, 2016.  
[39]  S. Tibby and I. Murdoch, "Monitoring Cardiac Function in Intensive Care," Archives of 
Disease in Childhood, vol. 88, no. 1, pp. 46-52, 2003.  
[40]  I. Kerslake and F. Kelly, "Uses of Capnography in the Critical Care Unit," British Journal 
of Anaesthesia, vol. 17, no. 5, p. 178–183, 2016.  
[41]  P. Theerawit, Y. Sutherasan, L. Ball and P. Pelosi, "Respiratory Monitoring in Adult 
Intensive Care Unit," Expert Review of Respiratory Medicine, vol. 11, no. 6, pp. 453-468, 
2017.  
[42]  C. Anderson and P. Breen, "Carbon Dioxide Kinetics and Capnography During Critical 
Care," Critical Care, vol. 4, no. 4, pp. 207-215, 2000.  
[43]  N. Mandal, "Respirometers Including Spirometer, Pneumotachograph and Peak Flow 
Meter," Anaesthesia & Intensive Care Medicine, vol. 7, no. 1, pp. 1-5, 2006.  
[44]  J. Toffaletti and C. Rackley, "Advances in Clinical Chemistry," in Chapter Three - 
Monitoring Oxygen Status, Elsevier, 2016, pp. 103-124. 
[45]  "Photoplethysmography and its Application in Clinical Physiological Measurement," 
Physiological Measurement, vol. 28, no. 3, pp. R1-R37, 2007.  
[46]  M. Delost, "Blood Gas and Critical Care Analyte Analysis," in Equipment for Respiratory 
Care, Jones & Bartlett, 2016, pp. 151-174. 
[47]  Y. Budak, K. Huysal and M. Polat, "Use of a Blood Gas Analyzer and a Laboratory 
Autoanalyzer in Routine Practice to Measure Electrolytes in Intensive Care Unit Patients," 
BMC Anesthesiology, pp. 12-17, 2012.  
78 
 
[48]  R. Pearse and A. Rhodes, "Mixed and Central Venous Oxygen Saturation," pp. 592-602.  
[49]  T. Koo, Measurement of Blood Analytes in Turbid Biological Tissue Using Near-infrared 
Raman Spectroscopy, Massachusetts: Massachusetts Institute of Technology, 2001.  
[50]  A. Draghici and A. Taylor, "The Physiological Basis and Measurement of Heart Rate 
Variability in Humans," Journal of Physiological Anthropology, vol. 35, no. 22, pp. 1-8, 
2016.  
[51]  C. Julien, "The Enigma of Mayer Waves: Facts and Models," Cardiovascular Research, 
vol. 70, no. 1, pp. 12-21, 2006.  
[52]  Y. Harati and S. Izadyar, "Chapter 12 – Autonomic Nervous System," in Neurology Secrets, 
Philadelphia, Mosby Inc., 2010, p. 204–226. 
[53]  G. Bishop, K. Shigemi, J. Freeman and M. Brunner, "Baroreflex Control of Arterial and 
Venous Compliances and Vascular Capacity in Hypertensive Dogs," American Journal of 
Physiology, vol. 265, no. 1, pp. H96-H102, 1993.  
[54]  A. Radaelli, R. Raco, P. Perfetti, A. Viola, A. Azzellino, M. Signorini and A. Ferrari, 
"Effects of Slow, Controlled Breathing on Baroreceptor Control of Heart Rate and Blood 
Pressure in Healthy Men," Journal of Hypertension, vol. 22, no. 7, p. 1361–1370, 2004.  
[55]  T. Lewis, "Studies of the Relationship Between Respiration and Blood-pressure," The 
Journal of physiology, vol. 37, no. 3, p. 213–232, 1908.  
[56]  L. Bernardi, C. Porta, A. Gabutti, L. Spicuzza and P. Sleight, "Modulatory Effects of 
Respiration," Autonomic Neuroscience, vol. 90, no. 1, p. 47–56, 2001.  
[57]  N. Selvaraj, A. Jaryal, J. Santhosh, K. Deepak and S. Anand, "Influence of Respiratory Rate 
on the Variability of Blood Volume Pulse Characteristics," Journal of Medical Engineering 
and Technology, vol. 35, no. 5, p. 370–375, 2009.  
[58]  V. Novak, P. Novak, J. De Champlain, A. Le Blanc, R. Martin and R. Nadeau, "Influence 
of Respiration on Heart Rate and Blood Pressure," Journal of Applied Physiology, vol. 74, 
no. 2, p. 617–626, 1993.  
[59]  C. Caro, T. Pedley, R. Schroter and W. Seed, The Mechanics of the Circulation, Cambridge: 
Cambridge University Press, 2012.  
[60]  G.R.A.S. Sound & Vibration, "G.R.A.S. 46AD 1/2" CCP Pressure Standard Microphone 
Set," G.R.A.S. Sound & Vibration, 2016. [Online]. Available: 
http://www.gras.dk/46ad.html. [Accessed 20 January 2017]. 
79 
 
[61]  G.R.A.S. Sound & Vibration, "G.R.A.S. 46AE 1/2'' CCP Free-field Standard Microphone 
Set," G.R.A.S. Sound & Vibration, 2016. [Online]. Available: 
http://www.gras.dk/46ae.html. [Accessed 20 January 2017]. 
[62]  National Instruments, "NI 446x Specifications," National Instruments, 2017. [Online]. 
Available: http://www.ni.com/pdf/manuals/373770j.pdf. [Accessed 20 January 2017]. 
[63]  Y. Cengel and J. Cimbala, Fluid Mechnanics: Fundamentals and Applications, New York: 
The McGraw-Hill Companies,Inc., 2014.  
[64]  E. Frederiksen, "Acoustic Metrology – An Overview of Calibration Methods and Their 
Uncertainties," International Iournal of Metrology and Quality Engineering, vol. 4, no. 2, 
pp. 97-107, 2013.  
[65]  Bruel & Kjaer, "Measurement Microphones," 1994. [Online]. Available: 
https://www.bksv.com/media/doc/br0567.pdf. 
[66]  J. Poruba, "Speech Enhancement Based On Nonlinear Spectral Subtraction," in IEEE 
International Caracas Conference on Devices, Circuits and Systems., Aruba, 2002.  
[67]  R. Udrea and S. Ciochinri, "Speech Enhancement Using Spectral Oversubtraction And 
Residual Noise Reduction," in International Symposium on Signals, Circuits and Systems, 
lasi, Romania, 2003.  
[68]  M. Okazaki, T. Kunimoto and T. Kobayashi, "Multi-Stage Spectral Subtraction For 
Enhancement Of Audio Signals," in IEEE International Conference on Acoustics, Speech, 
and Signal Processing, Montreal, Canada, 2004.  
[69]  S. Takada, S. Kanba, T. Ogawa, K. Akagiri and T. Kobayashi, "Sound Source Separation 
Using Null-Beamforming And Spectral Subtraction For Mobile Devices," in IEEE 
Workshop on Applications of Signal Processing to Audio and Acoustics, New Paltz, NY, 
2007.  
[70]  T. Tosanguan, R. Dickinson and E. Drakakis, "Modified Spectral Subtraction For De-
noising Heart Sounds: Interference Suppression via Spectral Comparison," in IEEE 
Biomedical Circuits and Systems Conference, Baltimore,MD, 2008.  
[71]  S. V. Vaseghi, Advanced Signal processing and Digital Noise Reduction, NY: John Wiley 
& Sons, Inc.,, 1996.  
[72]  S. Haykin, "Frquency - Domain Adaptive Filters," in Adaptive Filter Theory, New Jersey, 
Prentice Hall, Inc., 1996, pp. 445 - 478. 
80 
 
[73]  K. Hashiodani, T. Onoue, S. Takada, Y. Fukumizu and Y. Yamauchi, "Biosignals 
Separation Method For Medical Diagnostic System," in 5th International Symposium On 
Medical Information & Communication Technology (ISMICT), Switzerland, 2011.  
[74]  D. Flores-Tapia, Z. Moussavi and G. Thomas, "Heart Sound Cancellation Based on 
Multiscale Products and Linear Prediction," IEEE Transaction On Biomedical Engineering, 
vol. 54, no. 2, pp. 234 - 243, 2007.  
[75]  F. Jin, F. Sattar, S. Razul and D. Goh, "Heart Sound Localization From Respiratory Sound 
Using A Robust Wavelet Based Approach," in IEEE International Conference on 
Multimedia and Expo, Hannover, Germany, 2008.  
[76]  D. Percival and A. Walden, Wavelet Methods for Time Series Analysis, Cambridge: 
Cambridge University Press, 2000.  
[77]  A. Shcherbina, C. M. Mattsson, D. Waggott, H. Salisbury, J. W. Christle, T. Hastie, M. T. 
Wheeler and E. A. Ashley, "Accuracy in Wrist-Worn, Sensor-Based Measurements of 
Heart Rate and Energy Expenditure in a Diverse Cohort," Journal of Personalized 
Medicine, vol. 7, no. 3, p. 19, 2017.  
[78]  W. Karlen, H. Gan, M. Chiu, D. Dunsmuir, G. Zhou, G. A. Dumont and J. M. Ansermino, 
"Improving the Accuracy and Efficiency of Respiratory Rate Measurements in Children 
Using Mobile Devices," PLoS One, vol. 9, no. 6, pp. 1- 9, 2014.  
[79]  National Center for Chronic Disease Prevention and Health Promotion, Division for Heart 
Disease and Stroke Prevention, "Heart Disease Facts," Centers for Disease Control and 
Prevention, 2015. 
[80]  G. Clifford, I. Silva, B. Moody, Q. Li, D. Kella, A. Chahin, T. Kooistra, D. Perry and R. 
Mark, "False Alarm Reduction in Critical Care," Journal of Physiological Measurement, 
vol. 37, no. 8, pp. E5 - E23, 2016.  
[81]  S. C. Burrus, R. Gopinath and G. Haitao, Introduction to Wavelets and Wavelet Transform, 
New Jersey: Prentice-Hall, 1998.  
[82]  B. Christopher, Pattern Recognition and Machine Learning, Singapore: Springer, 2006.  
[83]  P. Rousseeuw, "Silhouettes: A Graphical Aid to the Interpretation and Validation of Cluster 
Analysis," Journal of Computational and Applied Mathematics, vol. 20, pp. 53 - 65, 1986.  
[84]  F. Marian and C. Elizabeth, "Fetal and Perinatal Mortality: United States, 2013," National 
Vital, vol. 54, no. 8, pp. 1 - 24, 2015.  
  
81 
 
[85]  WHEC Practice Bulletin and Clinical Management Guidelines for healthcare providers., 
"Intrapartum Electronic Fetal Monitoring," Women's Health and Education Center 
(WHEC), 11 December 2009. [Online]. Available: 
http://www.womenshealthsection.com/content/obs/obs028.php3. 
[86]  A. M. Ioyce, E. Brady, J. Michelle and C. Sally, "Births : Final Data for 2012," National 
Vital Statistics Report, U.S. Department of Health and Human Services, 2013. 
[87]  D. Ayres-de-Campos and J. Bernardes, "Twenty- Five Years after the FIGO Guidelines for 
the Use of Fetal Monitoring: Time for a Simplified Approach ?," International Journal of 
Gynecology & Obstetrics, vol. 110, no. 1, pp. 1 - 6, 2010.  
[88]  A. David and A. Lisa, "Electronic Fetal Heart Rate Monitoring : Applying Principles of 
Patient Safety," American Journal of Obstetrics & Gynecology, p. 6, 2012.  
[89]  P. Thomas, "Electronic Fetal Monitoring : A Bridge Too Far," The Journal of Legal 
Medicine, vol. 33, p. 72, 2012.  
[90]  E. Kennedy, Observations on Obstetric Auscultations, Dublin , Ireland: Hodges and Smith, 
1833.  
[91]  A. Cook, R. Yates and R. H. Anderson, "Normal and Abnormal Fetal Cardiac Anatomy," 
in Prenatal Diagnosis, John Wiley & Sons, Ltd., 2004, p. 1032–1048. 
[92]  M. Anisha, S. Kumar and M. Benisha, "Survey on Fetal ECG Extraction," in International 
Conference on Control, Instrumentation, Communication and Computational Technologies 
(ICCICCT), Kanyakumari,India, 2014.  
[93]  J. G. Stinstra, "The Reliability of Fetal Magnetocardiogram," Twente University Press, 
Netherlands, 2001. 
[94]  E. Zahedi and G. Beng, "Applicability of Adaptive Noise Cancellation to Fetal Heart Rate 
Detection Using Photoplethysmography," Computers in Biology and Medicine, vol. 38, no. 
1, pp. 31 - 41, 2008.  
[95]  T. Euliano, M. Nguyen, S. Darmanjian, S. Mcgorry, N. Euliano, A. Onkala and A. Gregg, 
"Monitoring Uterine Activity During Labor: A Comparison of Three Methods," American 
Journal of Obstetrics and Gynecology, vol. 208, no. 1, pp. 66.e1 - 66. e6, 2013.  
[96]  The American Institute of Ultrasound in Medicine, "AIUM Practice Guidelines for the 
Performance of Fetal Echocardiography," Journal of ultrasound in medicine: official 
journal of the American Institute, vol. 32, no. 6, pp. 1067 - 1082, 2013.  
82 
 
[97]  Z. Alfirevic, D. Devane and G. Gyte, "Continuous Cardiotocography as a Form of 
Electronic Fetal Monitoring For Fetal Assessment During Labour (Review)," Cochrane 
Database of Systematic Reviews, vol. CD006066, no. 5, 2013.  
[98]  A. Zukerwar, R. Pretlow, J. Stoughton and D. A. Baker, "Development of a Piezoploymer 
Pressure Sensor for a Portable Fetal Heart Rate Monitor," IEEE Transacations on 
Biomedical Engineering, vol. 40, no. 9, pp. 963 - 969, 1993.  
[99]  S. Noorzadeh, "Extraction of Fetal ECG and its Characteristics Using Multi-modality," 
Universite Grenoble Alpes, France, 2015. 
[100]  M. Hasan, M. B. I. Reaz, M. I. Ibrahimy, M. Hussain and J. Uddin, "Detection and 
Processing Techniques of FECG Signal for Fetal Monitoring," Biological Procedures 
Online, vol. 11, no. 1, pp. 263-295, 2009.  
[101]  J. Nagel, "New Diagnostic and Technical Aspects of Fetal Phonocardiography," Science 
Direct, vol. 23, p. 9, 1986.  
[102]  M. Pena, R. Gonzalez, T. Aljama, S. Carrasco, R. Ortiz and V. Valencia, "Comparision of 
Abdominal Ecg and Phonocardiography for Instantaneous Fetal Heart Rate Detection," in 
17th Annual Conference of IEEE Engineering in Medicine and Biology Society, Chicago, 
1997.  
[103]  M. Godinez, A. Jimnez, R. Ortiz and M. Pena, "Online Fetal Heart Rate Monitor by 
Phonocardiography," in IEEE, Cancun,Mexico, 2003.  
[104]  P. C. A. M. Bakker, G. J. Colenbrander, A. A. Verstraeten and H. Van Geijn, "The Quality 
of Intrapartum Fetal Heart Rate Monitoring," European Journal of Obstetrics & 
Gynecology and Reproductive Biology, vol. 116, no. 1, pp. 22-27, 2004.  
[105]  J. MacDonnell, "Knowledge Based Interpretation of Fetal Phonocardiographic Signals," in 
Transactions of the IEEE, 1990.  
[106]  S. Barnett and D. Maulik, "Guidelines and Recommendations For Safe Use of Doppler 
Ultrasound in Perinatal Applications," Journal of Maternal-Fetal and Neonatal Medicine, 
vol. 10, no. 2, p. 75–84, 2001.  
[107]  H. Kieler, S. Cnattingiust, B. Haglund, J. Palmgren and O. Axelsson, "Ultrasound and 
Adverse Effects," Ultrasound in Obstetrics and Gynecology, vol. 20, no. 1, pp. 102-103, 
2002.  
[108]  M. Ibrahimy, F. Ahmed, M. Ali and E. Zahedi, "Real-time Signal Processing for Fetal Heart 
Rate Monitoring," IEEE Transactions on Biomedical Engineering , vol. 50, no. 2, pp. 258 
- 261, 2003.  
83 
 
[109]  E. Ang, V. Gluncic, A. Duque, M. Schafer and P. Rakic, "Prenatal Exposure to Ultrasound 
Waves Impacts Neuronal Migration in Mice," Proceedings of the National Academy of 
Sciences, vol. 103, no. 34, pp. 12903-12910, 2006.  
[110]  J. Abramowicz, "Prenatal Exposure to Ultrasound Waves: Is There a Risk?," Ultrasound in 
Obstetrics and Gynecology, vol. 29, no. 10, p. 363–367, 2007.  
[111]  M. Ruffo, A. McEwan, A. Van Schaik, C. Sullivan, C. Jin, G. Gargiulo, M. Romano, M. 
Cesarelli, P. Bifulco and R. W. Shephard, "Non Invasive Foetal Monitoring with a 
Combined ECG-PCG System," INTECH Open Access Publisher, 2011. 
[112]  Y. Song, W. Xie, J. Chen and K. Phua, "Passive Acoustic Maternal Abdominal Fetal Heart 
Rate Monitoring Using Wavelet Transform," in IEEE Computers in Cardiology, Valencia, 
2006.  
[113]  J. Chen, K. Phua, Y. Song and L. Shue, "A Portable Phonocardiographic Fetal Heart Rate 
Monitor," in IEEE International Symposium on Circuits and Systems , Greece, 2006.  
[114]  A. Jimenez, M. Ortiz, M. Pena, S. Charleston, R. Gonzalez, A. Aljama and S. Cmasco, 
"Performance of a Method to Generate Fetal Cardiotachograms Using Fetal 
Phonocardiography," in IEEE Computer in Cardiology, Rotterdam,Netherlands, 2001.  
[115]  E. Abdulhay, R. Oweis, M. Alhaddad, N. Sublaban, A. Radwan and H. Almasaeed, 
"Review Article: Non-Invasive Fetal Heart Rate Monitoring Techniques," Biomedical 
Science and Engineering, vol. 2, no. 3, pp. 53 - 67, 2014.  
[116]  T. Balaji, C. Anirudh, R. Abhinav, J. Prashant and B. Neerja, "Fetomaternal Parameter 
Monitoring System". Patent WO2015082987 A1, 11 June 2015. 
[117]  P. Chetlur Adithya, R. Sankar, W. Moreno and S. Hart, "Trends in Fetal Monitoring 
Through Phonocardiography: Challenges and Future Directions," Biomedical Signal 
Processing and Control, vol. 33, pp. 289-305, 2017.  
[118]  M. Cesarelli, M. Ruffo, M. Romano and P. Bifulco, "Simulation of Foetal 
Phonocardiographic Recordings for Testing of FHR Extraction Algorithms," Computer 
Methods and Programs in Biomedicine, vol. I, no. 07, pp. 513 - 523, 2012.  
[119]  A. Ericsson, M. Crim and C. Franklin, "A Brief History of Animal Modeling," Journal of 
the Missouri State Medical Association, vol. 110, no. 3, pp. 201-205, 2013.  
[120]  J. Welch, P. Ford, R. Teplick and R. Rubsamen, "The Massachusetts General Hospital-
Marquette Foundation Hemodynamic and Electrocardiographic Database -- 
Comprehensive collection of critical care waveforms," Journal of Clinical Monitoring, vol. 
7, no. 1, pp. 96 - 97, 1991.  
84 
 
[121]  P. Chetlur Adithya, R. Sankar, W. Moreno and S. Hart, "A Novel Acoustic Catheter 
Stethoscope Based Acquisition and Signal Processing Framework to Extract Multiple Bio 
Signals," in IEEE Engineering in Medicine and Biology Society , Jeju Island, Korea, 2017.  
[122]  P. Chetlur Adithya, R. Sankar, W. Moreno and S. Hart, "A Novel Acquisition and Signal 
Processing Framework to Unmask Multiple Vital Bio Signals". US Provisional Patent 
62/454,507, 3 February 2017. 
[123]  P. Chetlur Adithya, R. Sankar, W. Moreno and S. Hart, "Systems And Methods For 
Determining Physiological Parameters From Blood Flow Dynamics". US Utility Patent 
15/888,889, 5 February 2018. 
[124]  P. Chetlur Adithya, S. Pandey, R. Sankar, S. Hart and W. Moreno, "Cluster Analysis 
Framework for Novel Acoustic Catheter Stethoscope," in NIH - IEEE Special Topics 
Conference on Healthcare Innovations and Point of Care Technologies: Technology in 
Translation, Baltimore, MD, 2017.  
[125]  P. Chetlur Adithya, S. Pandey, R. Sankar, W. Moreno, S. Hart and I. Ra, "Bio Acoustic 
Signal Feature Extraction and Pattern Recognistion Framework," in International 
Conference on Software & Smart Convergence, Vladivostok, Russia, 2017.  
[126]  P. Chelur Adithya, R. Sankar, W. Moreno, M. Cain, S. Hart, M. Simoes and C. Reyes, 
"Fetal Monitoring through Phonocardiography," in IEEE Engineering in Medicine and 
Biology Society, Chicago, 2014.  
 
 
  
85 
 
APPENDIX A: ADDITIONAL VALIDATION FOR NORMALIZED BLOOD PRESSURE 
 
For additional validation of normalized blood pressure data extracted from the novel 
catheter multiscope, a frequency domain benchmarking was also performed with human blood 
pressure.  The rationale behind establishing comparison between the human and animal blood 
pressure comes from the fact that specific animal models, particularly porcine and human 
physiological data share similar characteristics [119].  Figure A.1(a) shows the normalized 
continuous blood pressure computed from the catheter multiscope’s measurement and Figure 
A.1(b) shows the arterial blood pressure data extracted from the PhysioNet waveform multi-
parameter database [120, 25] over a period of ten seconds. 
 
Figure A.1: Normalized Blood Pressure of Catheter Multiscope and Arterial Blood Pressure 
from the PhysioNet Database. 
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This benchmarking was accomplished by estimating the magnitude squared coherence 
between the blood pressure data derived from recording index 1a and the Physionet arterial blood 
pressure using Welch’s overlapped segment averaging method with 5 second long frames and 75% 
overlap.  Figure A.2 presents the results of estimated magnitude squared coherence. 
 
Figure A.2: Estimated Magnitude Squared Coherence. 
It was observed that the magnitude squared coherence was dominant particularly around 2 
Hz and 7 Hz.  The Region of Interest (ROI) energy was estimated by computing the energy of the 
normalized magnitude squared coherence over 0 – 10 Hz and 10 – 20 Hz frequency bands.  The 
ROI energy indicated that the derived blood pressure and Physionet blood pressure were 
significantly correlated over a frequency band of 0 – 10 Hz.  The additional blood pressure 
validation results presented for the recording index 1a, shown in Figure A.2 is also applicable to 
other recording indices described in Table 3.1.
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